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During training and congested competition schedules, recovery strategies are 
thought to alleviate post-exercise fatigue and enhance subsequent performance. 
Consequently, a substantial challenge is placed on athletes and coaches to ensure 
optimal recovery is attained, this has been one of the contributing factors for the 
development of acute recovery strategies aimed to enhance performance recovery. 
Recently, athletes have incorporated the use of Intermittent Sequential Pneumatic 
Compression (ISPC), a form of dynamic compression, to enhance recovery post-
exercise. However, with contrasting findings and limited literature, further research 
is necessary to determine the value of ISPC on exercise recovery and/or subsequent 
performance. While ISPC has been examined in cycling settings, studies have failed 
to examine the effects of this strategy in trained cyclists, limiting the ecological 
validity of their results. Furthermore, the Omnium is a multi-race event in track 
cycling at the Olympic Games, with short periods of recovery (as little as 30-mins) 
between 6 separate races. Therefore, the objective of this investigation was to 
examine the impact of ISPC on trained cyclists, when implemented between a 
maximal 20-min cycling bout (simulated scratch race) and a 4-min maximal test 
(simulated individual pursuit), as experienced during an Omnium track cycling 
competition. Twenty-one (13 male, 8 female, mean ± SD; age: 36 ± 14 years) 
trained cyclists completed a familiarisation trial followed by two experimental trials 
in a counterbalanced, crossover design. Participants performed a fixed-intensity 20-
min cycling bout on a Wattbike cycle ergometer, followed by a 30-min recovery 
period where ISPC recovery boots or passive recovery (CON) was implemented. 
At the conclusion of the recovery period, participants performed a 4-min maximal 
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cycling bout (4-minTT). Average power (Watts) for the 4-minTT, blood lactate 
concentration (BLa) and perceived total quality recovery (TQR) during the 
recovery period were used to examine the influence of ISPC.  
There were no significant differences between trials for the 4-minTT (p = 0.08), 
with the effect deemed to be trivial (d = -0.08). There was an unclear effect (d 
±90%CI = 0.26 ±0.78, p = 0.57) for ISPC vs CON in the clearance of BLa during 
the recovery period. There was a small but not significant difference for TQR in 
favour of ISPC (d ±90%CI = 0.27 ±0.27, p = 0.07). These findings suggest there is 
little additional benefit associated with the use of ISPC to enhance recovery and 
subsequent performance when used during the recovery period between two events 
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The current thesis is comprised of three chapters. Chapter one contains a review of 
literature and introduces the reader to post-exercise recovery strategies in cycling. 
Chapter two focuses on an original investigation examining a novel post-exercise 
recovery strategy in cyclists; termed ‘Intermittent Sequential Pneumatic 
Compression’. Chapter three provides recommendations for future recovery 
research in cyclists. Both chapter one and chapter two, are presented in the style of 






Acute Post-Exercise Recovery Strategies in Cyclists: 





There are many disciplines in professional cycling such as track cycling, road 
cycling, mountain biking and bicycle motocross (BMX).1-3 Road cycling can be 
considered one of the most arduous sports, with professional cyclists training one 
or more times per day, for durations of up to 5 hours per training session and 6-8 
times per week.1, 4 Furthermore, the Tour De France is a road cycling stage race, 
considered one of the most difficult sporting endurance competitions, with riders 
competing at average speeds >40kph, up to 5 hours per day, over three weeks.5 
Additionally, many of the cycling disciplines involve multiple races a day or racing 
over consecutive days.3, 4, 6 During training and congested competition schedules, 
recovery strategies are thought to alleviate post-exercise fatigue and enhance 
subsequent performance.7, 8 Consequently, a substantial challenge is placed on 
athletes and coaches to ensure optimal recovery is attained, and has been one of the 
contributing factors for the development of novel recovery strategies to enhance 
performance.8, 9 The main purpose of this review is to summarize the scientific 
literature on acute post-exercise recovery strategies, implemented in the sport of 
cycling. 
Literature Search 
Based on a search of Google Scholar, SPORTDiscus, Web of Science, 
MEDLINE/PubMed and Cochrane databases, to our knowledge, there is currently 
no published review examining the literature on recovery strategies used with 
cyclists as the participants of interest. The relevant literature for this review was 
obtained from a search within the Google Scholar, MEDLINE/PubMed, 
SPORTDiscus, Web of Science and Cochrane databases. Included terms for the 
searches were: “Recovery strategies cyclists/cycling”, “cold water immersion 
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cyclists/cycling”, “active recovery cyclists/cycling”, “electromyostimulation 
cyclists/cycling”, “massage recovery cycling/cyclists”, “compression recovery 
cyclists/cycling”, “compression garments recovery cycling/cyclists”, “cryotherapy 
cyclists/cycling”, “water immersion recovery cyclists/cycling”, “hydrotherapy 
recovery cyclists/cycling”, “static stretching recovery cyclists/cycling”, “dynamic 
stretching recovery cyclists/cycling”, “ice cyclists/cycling”, “sequential 
intermittent pneumatic compression cyclists/cycling”, “dynamic compression 
cyclists/cycling”, “intermittent pneumatic compression cyclists/cycling”. The 
inclusion criteria was limited to the English language and studies published prior to 
August 2017. Twenty-seven studies were included for analysis. Recovery strategies 
examined include active recovery (AR), sports massage (SM), cold water 
immersion (CWI), compression garments (COMP), electromyostimulation (EMS), 
humidification therapy (HUM), passive recovery in water (PRW), active recovery 
in water (ARW), static stretching (SS), contrast water therapy (CWT), compression 
stockings (CS), hot water immersion/therapy (HWI), cold compression therapy 
(CCT) thermoneutral water immersion (TWI) and a combination of active recovery 
and sports massage.  
Fatigue in Cycling 
In order to discuss the potential fatigue mechanisms associated with cycling, one 
must first determine the duration of the event.10 For example, while the winning 
time for the men’s Omnium flying lap race at the 2016 Rio Olympics was 12.506s, 
the winning time for the road race was 6:10:05s; resulting in a variance in exercise 
intensity, energy utilization and associated fatigue.1, 11 Therefore, cycling events 
have been categorized with race duration (table 1). The following chapter provides 
a general overview of fatigue associated with the category durations provided.  
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Table 1. Men’s Cycling Events Categorised According to Duration. 
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Fatigue During Sprint Cycling 
Humans only have Adenosine Triphosphate (ATP) reserves for ~2 seconds of 
maximal contraction,12, 13 Since ATP serves as the currency for the production of 
mechanical work, one can expect that a reduction in ATP leads to a state where the 
capacity to produce mechanical work is reduced.12 In a brief event such as sprint 
cycling (i.e. 200m track sprint), energy production is highly dependent on the 
anaerobic glycolytic system.1 For example, during a 200m track sprint, the alactic 
and anaerobic glycolytic systems contribute 40 and 55% of energy production, 
respectively.1 Therefore, performance decrements in these events have been 
attributed to a combination of ‘peripheral metabolic’ and ‘central/neural’ 
mechanisms.10, 14 Peripheral metabolic mechanisms are associated not only to a 
breakdown of phosphocreatine (PCr) and a subsequent increase in inorganic 
phosphates (Pi), but also to a reduction in cross-bridge cycling and force 
production.15 Neural mechanisms include a reduction of the central nervous system 
(CNS) to drive motor neurons; therefore decreasing the number of active motor 
units (MU), including those innervating fast twitch muscle fibres, responsible for 
maximal force production.14, 16 Thus, a reduction in the capability to recruit fast 
twitch MU, will ultimately result in a reduction of power output during sprint 
cycling.14 
 
Fatigue During Short-duration Cycling 
During short-duration events (table 1), the anaerobic and aerobic systems contribute 
to the vast majority of energy production.1 For example, during a female 500m 
cycling sprint (duration ~35s), the anaerobic glycolytic and aerobic contribution is 
suspected to be 45 & 35%, respectively.1 Moreover, the anaerobic glycolytic and 
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aerobic contribution during a male 1000m track cycling event (duration ~60s) is 
suspected to be 40 & 50%, respectively.1 Conversely, the alactic system is believed 
to only contribute 10-20% of total energy production during events of this duration.1 
The dependency on the anaerobic glycolytic system, is associated with an increase 
in metabolites and therefore a loss of muscle function.17-19 While traditionally 
thought that increased H+ was the main metabolite which contributed to fatigue,
17 
Degroot and colleagues20 have revealed that an increase in Pi and monovalent 
phosphate (H2PO4
-), are better correlated with a reduction in maximum voluntary 
contraction than H+. An extensive review on the effects of metabolism end products 
and acidosis on muscle fatigue can be found elsewhere.17-19 Alike with sprint 
cycling, a reduction in the capability to recruit fast twitch MU due to CNS fatigue, 
will ultimately result in a reduction of power output during short-duration cycling.14 
 
Fatigue During Middle-duration Cycling 
Middle-duration events in cycling range from a duration of between 3 to 18-mins 
(table 1). Therefore, the metabolic contribution from these events are highly 
dependent on the anaerobic glycolytic and aerobic system, with a minor 
contribution from the alactic system (~1%).1 For example, in the male 4-km TT (~4 
min duration) the anaerobic glycolytic system contributes 14% of energy 
production, while the aerobic glycolytic system contributes a greater 85% of energy 
production.1 As a result of the high aerobic demand of cycling within this category, 
a limiting factor of performance is the ability of the cardiovascular system to supply 
sufficient oxygen to the working muscle.21 Middle-duration events occur on the 
severe intensity domain where power outputs are generated above critical power 
(CP) and sustained until VO2max is achieved.
22 Performing above CP during cycling 
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tasks has been linked to a reduction of muscle PCr, potential of hydrogen (pH), 
ATP and a concomitant increase in Pi, plasma potassium ion (K
+) and blood and 
muscle lactate.11 A reduction in PCr and ATP concentration has been associated 
with an increase in electromyography (EMG) signals, demonstrating an attempt of 
the CNS to compensate for increased peripheral fatigue.11 Moreover, a rise in 
extracellular K+ will result in a decrease of action potential conduction, leading to 
a reduction of calcium ion (Ca2+) release from the sarcoplasmic reticulum and a loss 
of contraction force.23 An increase in plasma K+ content has been correlated with 
an increase in neural drive (r=0.64); believed to be a strategy to maintain power 
output production.11 For the aforementioned reasons, fatigue during cycling within 
middle-durations can be associated to metabolic depletion (PCr and ATP), 
metabolite accumulation (Pi, plasma K
+ and blood and muscle lactate) and 
neuromuscular fatigue (increased CNS activity). 
 
Fatigue During Endurance Cycling 
Endurance cycling events range from approximately 45-mins to ~6-hrs (table 1). 
Numerous models to explain fatigue during cycling within this category include but 
are not limited to; the energy depletion, metabolite accumulation, muscle trauma 
and neuromuscular fatigue models, and the reader is directed to an extensive review 
conducted elsewhere.21 Given the duration of these events, energy is predominantly 
produced from the aerobic system.1 Alike with middle-duration cycling and due to 
the high aerobic demand of this category, a limiting factor of performance is the 
ability of the cardiovascular system to supply sufficient oxygen to the working 
muscle.21  Furthermore, metabolic disturbances include a reduction in PCr, ATP, 
pH and glycogen, with a concomitant increase in blood and muscle lactate and K+; 
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believed to disrupt Ca2+ release and result in a loss of contraction force.11 
Additionally, prolonged endurance cycling results in a severe depletion of liver and 
muscle glycogen11, 21 and reductions in voluntary strength.24 A further explanation 
for an increase in fatigue and consequent reduction in power output could be 
mechanical damage, resulting from muscle cell disruption.25  Alterations of 
neuromuscular functions during prolonged cycling exercise has been reviewed 
elsewhere.24 Therefore, fatigue during endurance cycling is highly complex and 
multifaceted, categorized by a series of afferent feedback mechanisms, designed to 
protect a cyclist from overexerting, otherwise leading to injury or death.21 
 
Recovery Modalities in Cycling 
Compression Garments (COMP) 
Compression garments, or static compression, are thought to improve exercise 
recovery through the application of pressure at the extremity i.e. ankle, thereby 
enhancing venous blood flow, cardiac output and stroke volume which in turn, 
assists in the removal of metabolic waste accumulated as a result of exercise.8 There 
are two types of static compression that have been examined in cycling literature: 
Compression stockings6, 26 and full-length tights.8, 27 The ability of static 
compression to improve subsequent performance, perceived muscle soreness and 
muscle swelling, appears to be irrespective of garment type and pressure exerted, 
with both compression stockings and full-length tights, shown to attenuate the 
decrement in mean and max power, decrease thigh girth, calf girth and perceived 
muscle soreness, post-recovery when compared with a passive control (table 3).6, 8, 
26, 27 However, it is worth noting, that not all studies quantified the actual pressure 
exerted by the garments used (table 2). Menetrier and colleagues6 discovered an 
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increase in subsequent performance mean power of 1.8 ± 1.0% during 5-mins of 
maximal cycling, from the use of compression stockings for 12-mins during 
recovery when compared with a passive control. Full length tights and compression 
stockings used for 12-80mins have been shown to improve the rate of BLa removal 
following 10-min cycling beginning at 80% and increasing to 90% PPO, 30-min 
cycling beginning at 70% and increasing to 100% PPO and 5-mins of maximal 
cycling.6, 26, 27 However, full length tights were no more beneficial than passive rest 
alone, at reducing BLa concentration following 30s of maximal sprint cycling.8 
Furthermore, COMP resulted in no change in HR measures, TQR or RPE when 
compared with a control.6, 8, 26 It should not be discounted that a psychological 
advantage by means of a placebo effect is responsible, at least in part, for the 
resultant performance benefits. A study by Argus and colleagues8 attempted to 
control for a placebo effect through use of a belief questionnaire. Participants were 
required to predict whether or not the recovery intervention would enhance their 
recovery and results revealed that only 2/8 participants accurately predicted the best 
strategy. Therefore indicating that a placebo effect may not be responsible for the 
resultant performance benefits associated with COMP. While it is unclear whether 
a biochemical mechanism is responsible for improved recovery and performance 
from the use of COMP, it is evident that there is a correlation between a reduction 
in muscle swelling and perceived soreness and a consequent enhancement or 
maintenance of subsequent mean and maximal cycling power, and COMP proves 
to be a worthwhile addition to the cyclists/coaches recovery toolbox. 
Future research should continue to use a valid and reliable method of pressure 
monitoring such as the Kikuhime28 to continue to examine whether there is a 
relationship between pressure exerted and resultant benefits in cyclists. To better 
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understand whether a placebo effect is responsible for the benefits associated with 
COMP, researchers should continue to use a visual analogue scale29 to examine 
‘belief’.  
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COMP ↓ thigh girth vs CON  
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COMP ↓ calf girth vs CON  
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CWT ↑ mean power vs CON (368 ± 12 W, +4.1 ± 
0.7 %; p < 0.001)  
 
CS ↑ mean power vs CON (361 ± 15 W, +1.8 ± 1.0 
%; p < 0.05) 
 
CWT ↑ mean power vs CS (+2.2 ± 0.8 %; p < 0.05) 
 
CWT & CS ↓ BLa vs CON (CWT: 5.7 ± 1.0 
mmol·L-1; p < 0.001, CS: 7.3 ± 1.2 mmol·L-1;  
p < 0.05 / CON: 8.4 ± 1.0 mmol·L-1) 
 
CWT ↓ BLa vs CS (p < 0.05)  
 
CWT & CS ↓ perceived muscle soreness vs CON 
(CWT: 1.1 ± 0.5 au; p < 0.001 / CS: 1.6 ± 0.4 au;  
p < 0.001 / CON: 3.2 ± 0.5 au) 
 
HR during exercise & RPE no sig dif between 
conditions (p > 0.05) 
CWT & CS > CON ↑ 
mean power 
 
CWT > CS ↑ mean power 
 
CWT & CS > CON ↓ 
BLa  
 
CWT > CS ↓ BLa 
 




CWT, CS & CON  = HR 
during exercise and RPE 
N number of cyclists, W/Kg watts per kilogram of bodyweight, COMP compression garment/full length tights, EMS electromyostimulation/electronic muscle stimulation, HUM  
humidification therapy, CON control condition/passive rest, BLa blood lactate concentration, TQR perceived total quality recovery, VO2max maximal oxygen uptake, PPO peak 




Cold Water Immersion (CWI) 
Cold water immersion is the most researched recovery strategy in cycling literature 
(table 4). Athletes exercising in the heat are advised to maintain a narrow core 
temperature of between 37-39°C to optimise performance; a rise of core 
temperature beyond 39°C can result in increased perceived fatigue, a reduction in 
exercise performance and premature exercise termination.30, 31 CWI has also been 
suggested beneficial for the treatment of inflammation and perceived pain.32 When 
using CWI to mitigate hyperthermia, it would be assumed that longer immersion 
durations may be beneficial. However, 5-mins of CWI was just as effective at 
reducing core temperature when compared to 10 and 20-mins.33 The same authors 
speculate that involuntary contraction from shivering due to longer durations (10-
mins or more) in cold water, leads to increased metabolic heat development. Due 
to the large number of studies examining CWI in cyclists, performance recovery 
and physiological variables will be examined separately for this recovery modality. 
 
Cold Water Immersion for Performance Recovery 
When considering the use of CWI for cycling performance, there are five common 
variables examined a) Power (peak power output, mean power output) b) Time 
(time to completion, exhaustion or PPO) c) Total work performed d) 
Isokinetic/isometric muscular contraction (maximum voluntary isometric 
contraction, isokinetic/isometric torque).  
 
Power 
Three studies have reported improvements in power measures9, 30, 34 while a further 




these studies failed to utilise a control group in their design.39 Only one study 
reported CWI as detrimental to power output.40 During a 4-km TT in the heat 
(35°C), power output was reduced by 20 ± 6% in a control condition, where CWI 
was able to attenuate this decrement to only a 3 ± 3% reduction in power output.30 
During 66 ramped sprints beginning at 5s and working up to 15s per sprint, CWI 
was able to improve sprint power measures over 3 days when compared with a 
control (within-trial change mean ± 90%CL, CWI: +2.4 ±2.3 % vs CON: -9.6 ±5.0 
%).9 This improvement in both time trial and sprint performance was further 
supported by Vaile and colleagues34 who used the same sprint protocol as the 
aforementioned study and revealed up to a 1.4% increase in mean power over 5 
days and a better maintenance of power when compared with  a control on days 4-
5 (p < 0.01). During a 9-min TT comprised of 2 x 2-min TT’s and 1 x 5-min TT, 
CWI improved mean power by up to 1% over 5 days, where the control condition 
reduced power by up to 3.8% over the same 5 day period.34 In the studies exhibiting 
no improvement in power output from CWI, two studies utilised the same recovery 
protocol, which included 5-mins of the condition and a further 15-mins passive 
seated.35, 36 Further studies had extensive recovery durations which may have 
diluted the impact of the recovery intervention such as the study by Christensen & 
Bangsbo,37 who used CWI for 15-mins and then followed this with a 2h 35m rest 
period. Stanley and colleagues38 had a similarly long protocol, using CWI for 5-
mins and then followed this with 2h 45m passive rest. Additionally, in a later study 
by Stanley and colleagues9 the authors reported no improvement in power during 
cycling time trials. However, these time trials were preceded by 66 ramped sprints, 
from which they saw CWI attenuated sprint power by up to 12% over 3 days when 




an effect would have been observed. In the one study that revealed CWI was 
detrimental to performance,40 participants were required to push a very large gear, 
using a 53 tooth chainring and a 13 tooth rear sprocket, totalling 110 inches per 
cycle revolution, in a short duration of 30s and participants were confined to this 
one gear. This may have led to participants being unable to overcome the resistance 
effectively, while other participants could have found this resistance easier, 
especially considering there was a 9.9kg deviation in weight and the level of 
experience varied among riders (category rank, training miles per year and races 
per year). Additionally, studies that examined subsequent performance and reported 
benefits from the use of CWI had an acclimation period consisting of a significant 
warm-up34 or 10-mins passive rest post CWI,30 where Schniepp and colleagues40 
required participants to towel dry and immediately remount their bicycles. Indeed, 
it has been suggested that a reduction in muscle temperature can impair cross-bridge 
cycling, motor unit activation and enzyme activity rate40 which perhaps is mitigated 
by the use of passive rest or a warm-up post condition.  
 
Time 
CWI used for 5-mins (14°C) and with 10-mins passive rest pre & post CWI, was 
able to improve 4-km TT time to completion in the heat (35°C, 40% rh) by 18 ± 
11.5 seconds.30 However, increasing the passive rest duration from 10 to 15-mins 
post CWI, despite using the same water temperature (14°C) was unable to improve 
1-km TT time to completion performance in the same environmental conditions in 
two studies.35, 36 Stanley and colleagues 38 also reported no significant difference in 




to rest extensively (2h 45m) before completing their performance trial which would 
have diluted the impact of the recovery intervention.  
 
Total work performed 
Three studies improved total work performed when using CWI.31, 32, 34 Following 
66 max sprints and a 9-min TT, CWI (15°C) used for 14-mins over 5 consecutive 
days improved TT total work performed on days 4 & 5 (p < 0.05); with a 5 kJ 
improvement in mean TT total work on the 5th day.34 Furthermore, while no passive 
rest control condition was examined, CWI (15°C) used for 15-mins and followed 
by 40-mins passive rest, improved total worked performed; while AR (40% PPO) 
resulted in a reduction of total work performed (CWI: +0.10 ± 0.7%, AR: -1.8 ± -
1.1%).32 In an earlier study by Vaile and colleagues31 CWI was again superior when 
compared to AR and maintained 30-min cycling total work between bouts while 
AR decreased total work by 4.1 ± 1.8 % (p = 0.00). Only one study revealed no 
significant difference in total work performed from the use of CWI41 and can be 
attributed to a long recovery duration consisting of 25-mins passive rest, 20-mins 
per condition and a further 45-mins passive rest (total = 1.5h) before the 
performance trial.41 
 
Isokinetic/Isometric muscular contraction 
CWI’s impact on isometric and isokinetic force production following cycling is 
confounding. Peiffer and colleagues41 revealed that maximum voluntary isometric 
contraction was reduced from the use of CWI 45 & 90-mins post 16.1km TT when 
compared to a passive control. In this study, authors compared the use of electrical 




results revealed no significant difference between maximum voluntary isometric 
contraction and maximum voluntary isometric contraction with superimposed 
electrical stimulation (p < 0.05), it was suggested that the limiting factor was related 
to a reduction in blood flow as examined by a reduction in venous vessel diameter 
90-mins post TT. Furthermore, later studies by the same author33, 35 revealed no 
significant difference in isometric and isokinetic torque.  
 
Cold Water Immersion for Recovery 
When compared with a passive seated control, CWI decreased HR post-recovery 
by 4.2 % when used for 15-mins between sprint cycling of 30s40 and also reduced 
HR overtime (post-exercise to 40-mins post-exercise) by 10 b·min
-1 42. On day one 
of a three day protocol, CWI also significantly decreased HR post-recovery.9 In 
addition to improved HR post-recovery, CWI consistently increased HRV measures 
with large effect sizes.9, 36, 38 
Perceived recovery measures revealed that CWI improved ratings of perceived 
physical and mental recovery, reduced perceived muscle soreness and perceived 
general fatigue.36, 42 Stanley and colleagues38 also revealed similar improvements 
in a reduction of perceived general fatigue, leg soreness and an increase in physical 
recovery however, no significant difference was observed in mental recovery. This 
trend also occurred in a later study by the same author9 who observed a reduction 
in perceived leg soreness from CWI however, perceived mental recovery and 
perceived tiredness were unclear between conditions. Christensen and Bangsbo37 
was the only study to examine perceived readiness and results revealed there was 




Tre was reduced post-recovery by 0.4°C,
30 40-mins post-exercise (CWI: ∆1.99 ± 
0.50 °C, CON: ∆1.49 ± 0.50 °C, p = 0.01),42 2.5-3% 80-mins post-exercise33 and a 
statistically significant reduction was observed 90-mins post-exercise.41 
Surprisingly and alike with HR, Buchheit and colleagues36 reported no significant 
difference when CWI was used 20-mins between 1-km maximal cycling in the heat. 
This was further supported by Peiffer and colleagues35 who used the same exercise 
protocol and recovery duration. Furthermore, CWI was ineffective at reducing Tre 
when used for 14-mins following 66 max sprints and a 9-min TT.34 In the one study 
that compared body temperature between CWI and a control,42 results indicated that 
following a 40-min TT and 20-mins passive rest in the heat (34.3 ± 1.1°C, 41.2 ± 
3.0% rh), CWI used for 3 x 60s with 2-mins seated rest in ambient temperatures 
between immersion, reduced mean body temperature post-exercise to 40-mins post-
exercise (CWI: -6.3 %, CON: -3.8 %, p < 0.05). In addition to a reduction in body 
temperature, CWI has been shown to reduce Tmus 45-mins post a time to exhaustion 
test in the heat33 and following a 1-km cycling TT in the heat.35 Tsk was also reduced 
from the use of CWI post-exercise to 40-mins post-exercise (CWI: -20.2 %, CON: 
-3.7 %, p < 0.05).42 
BLa results are difficult to interpret as no significant difference (p = 0.11) was 
observed following a 4-min TT37 however, performance was also not improved in 
the current study and when CWI was used following a 40-min TT in heat,42 BLa 
again revealed no significant difference however, subsequent performance was not 
examined. 
Road cycling events result in short resting durations and in events such as stage 
races, the resting location is not always the same.39 Therefore, CWI is not always 




colleagues39 have examined the use of a dynamic form of cold compression (Game 
Ready; CoolSystems, Concord, CA, USA). However, results indicated that the 
device was no more beneficial than AR or CWI at attenuating mean power, RPE or 
HR following 30-mins cycling comprised of 15-mins at 75% PPO and a 15-min 
maximal cycling TT in the heat (31°C). Furthermore, AR was more beneficial than 
dynamic cold compression at reducing BLa measures; indicating that the use of an 
indoor bicycle bike roller to perform AR between events may be more effective 
than dynamic cold compression for enhancing recovery when an immersion pool is 
not practical or available.  
 
CWI has been shown beneficial for improving both cycling TT power and reducing 
time to completion, particularly when used at 14°C for 5-mins. When used at 15°C 
for 15-mins, CWI has been shown to improve total work performed during cycling 
TT’s and sprints. CWI has also been shown more beneficial than AR at improving 
total work. While CWI was detrimental to isokinetic and isometric muscle 
contraction, isometric muscle testing is perhaps not a valid method of performance 
reporting for cyclists due to the concentric demand of cycling. These performance 
benefits were associated with a reduction in HR recovery, increased HRV, a 
reduction in body temperature, Tmus and Tsk and increased perceived recovery. CWI 
was not able to improve perceived mental recovery, tiredness or readiness.  
To better understand the role of BLa in performance from the use of CWI, future 
research should explore a subsequent performance bout and examine BLa pre and 
post recovery. Furthermore, not using a control condition confounds results as 
benefits can be observed from other recovery modalities and a passive seated 




and authors should implement recovery durations with greater ecological validity. 
To avoid limiting the impact of a recovery intervention, cyclists should not be 
confined to one gear during a performance trial and be allowed to dictate the load. 
Certainly, the pre-fatiguing exercise protocol can be controlled to ascertain the 




























(age = 27 ± 7 
years; VO2max = 
61.7 ± 5.0 
mL·Kg-1·min-1) 
 















Pre & Post in 
heat (32.2 ± 
0.7 °C, 55 ± 












CWI (14.3 ± 0.2°C, 
mid sternum level) 
 
Passive seated 













16.1-km TT total 












No sig dif between conditions for TT total 
work performed, post-exercise Tsk , post-
exercise Tre and post-exercise femoral vein 
diameter 
 
CWI ↓ Tsk vs CON 25-90mins post TT  
 
CWI ↓ Tre  vs CON 50-90mins post TT 
 
CWI ↓ MVIC & SMVIC vs CON 45 & 90-
mins post TT 
 
CWI ↓ femoral vein diameter vs CON 45-
mins post TT 
 
 
CWI & CON = TT 
total work performed, 
post-exercise Tsk, post-
exercise Tre and post-
exercise femoral vein 
diameter 
 
CWI > CON ↓ Tsk 25-
90mins and Tre 50-
90mins post TT 
 
CON > CWI 
maintaining MVIC & 
SMVIC 45 & 90mins 
post TT and femoral 















(age = 35 ± 7 
years; VO2max = 
60.5 ± 4.5 
mL·Kg-1·min-1; 
PPO = 441 ± 32 
W)  
 
N = 10 




session (254 ± 
22 W @ 65% 
VO2max) and  
4-km TT in 
heat (35°C, 
40% rh) 
CWI (14°C, mid 
sternum level) 5-
mins + 10-mins 
passive seated pre 
and post CWI 
 
Passive seated in 













4-km TT in heat 
(35°C) time to 
completion & power 
output and  
RPE 
CWI ↓ Tre vs CON post-recovery (CWI: 38.2 
± 0.2 °C, CON: 38.6 ± 0.5 °C; p < 0.05) 
 
No sig dif VO2 between conditions 
 
CWI attenuated ↓ cadence vs CON (CWI: 88 
± 6 rpm, CON: 85 ± 7 rpm, p < 0.05) 
 
CWI ↓ TT time to completion (-18 ± 11.5 
seconds, p < 0.05) and RPE (CWI: 15 ± 2, 
CON: 17 ± 1, p < 0.05) vs CON  
 
CWI attenuated ↓ TT average power output vs 
CON (CWI: -3.0 ± 3.0 %, CON: -20 ± 6.0%,  
p < 0.05) 
 
CWI > CON ↓ Tre post-
recovery 
 
CWI & CON = VO2 
 
CWI > CON ↓ time to 
completion and 
attenuating ↓ average 
power output and 
cadence 
 
CWI > CON ↓ RPE 
Peiffer et al, 
200835 
Male cyclists 
(age = 29 ± 6 
years; VO2max = 
56.5 ± 5.0 
mL·Kg-1·min-1) 
 
N = 10 
Pre & post: 
1-km cycling 
TT in heat (35 










CWI (14°C, mid 
sternal level) 5-
mins + 15-mins 


























Tre and isokinetic quadriceps torque no sig dif 
post-recovery between conditions  
 
CWI ↓ quadriceps Tmus (CWI: 36.4 ± 0.8 °C, 
CON: 37.7 ± 0.3 °C, p < 0.001) 
 
No sig dif PPO, average power and time to 
completion between conditions (p = 0.42 to 
0.50)  
CWI > CON ↓ 
quadriceps Tmus in heat 
 
CWI & CON = PPO, 
average power, time to 
completion and rectal 









Peiffer et al, 
200933 
Male cyclists 
(age = 29 ± 3 
years; VO2max = 
64.0 ± 5.7 
mL·Kg-1·min-1; 
PPO = 435 ± 45 
W) 
 




test in heat 
(40°C, 40% 
rh, 57 ± 7 % 
VO2max) 
CWI x 5-mins 
(CWI5) [14°C, mid 
sternum level] 
 
CWI x 10-mins 
(CWI10) [14°C, 
mid sternum level] 
 
CWI x 20-mins 
(CWI20) [14°C, 
mid sternum level] 
 
Passive seated x 20-

















Time to exhaustion 
(min) 
 











No sig dif between conditions for time to 
exhaustion & total work performed 
 
CON ↑ Tre vs all CWI conditions 75-mins & 
80-mins post-exercise 
 
CWI ↓ Tre 45-80mins post time to exhaustion 
test (CWI5: -2.8 ± 0.8 %, CWI10: -2.5 ± 0.7 
%, CWI20: -3.0 ± 1.1 %, CON: -1.2 ± 0.6 %) 
 
CWI ↓ Tmus vs CON 45-mins post time to 
exhaustion test (CWI5: 34.1 ± 1.1 °C, CWI10: 
33.2 ± 1.2 °C, CWI20: 32.5 ± 21.1 °C, CON: 
36.4 ± 0.7 °C) 
 
CWI10 & CWI20 ↓ Tmus vs CWI5 
immediately post-recovery (CWI5: 35.4 ± 1.4, 
CWI10: 34.1 ± 1.9 °C, CWI20: 32.5 ± 2.1 °C)  
 




CWI5, CWI10, CWI20 
& CON = time to 
exhaustion and total 
work performed 
 
CON > CWI5, CWI10 
& CWI20 ↑ Tre 75 & 
80-mins post exercise 
CWI5, CWI10 & 
CWI20 > CON ↓ Tre 
45-80mins post time to 
exhaustion test 
 
CWI5, CWI10 & 
CWI20 > CON ↓ 
muscle temperature 
45-mins post time to 
exhaustion test  
 
CWI10 & CWI20 > 





CWI5, CWI10, CWI20 
& CON = isometric 



















(age = 23.8 ± 
1.6 years; 




N = 11 
Pre: 
~40-min TT in 
heat (34.3 ± 
1.1°C, 41.2 ± 






of work (kJ) 
as first 20-min 
but completed 






(CON) [24.2 ± 





rest followed by  
 
3 x 60s per 
conditions with 2-
mins seated rest 
between [24.2 ± 
















pH, chloride, glucose, 
bicarbonate, 
potassium, sodium, 
PCO2, PO2, plasma 
CK, IGF-1, 
testosterone, GH, 
















CWI ↓ HR over time (post-exercise to 40mins 
post-exercise) (CWI: ∆116 ± 9 b·min-1, CON: 
∆106 ± 4 b·min-1, p = 0.02)  mean body 
temperature over time (CWI: -6.3 %, CON: -
3.8 %, p < 0.05)  Tsk over time (CWI: -20.2 %, 
CON: -3.7 %, p < 0.05) and  PO2 40-mins 
post-exercise (CWI: 59.46 ± 10.40 mmHg, 
CON: 67.71 ± 9.07 mmHg, p = 0.015) vs 
CON 
 
CWI ↓ Tre vs CON 40-mins post-exercise 
(CWI: ∆1.99 ± 0.50 °C, CON: ∆1.49 ± 0.50 
°C, p = 0.01) 
 
CWI ↑ cooling rate (CWI: 0.009 ± 0.03 
°C·min-1, CON: 0.001 ± 0.001 °C·min-1, p < 
0.05), ratings of perceived physical recovery 
(CWI: 6.8 ± 1.5, CON: 6.4 ± 1.7) and mental 
recovery vs CON (CWI: 6.7 ± 1.8, CON: 6.1 
± 1.7) 
 
No sig dif between conditions for PH, 
chloride, glucose, bicarbonate, potassium, 
sodium, PCO2, CK, IGF-1, testosterone, GH, 
plasma CRP, IL-6, cortisol concentration, 
plasma prolactin concentration, plasma 
adrenaline and plasma noradrenaline or BLa  
 
CWI ↓ perceived muscle soreness (CWI: 3.8  
± 2.6, CON: 5.0 ± 2.9) and general fatigue 
(CWI: 5.3 ± 2.0, CON: 6.3 ± 2.0) vs CON 
 
CWI > CON ↓ HR, Tre, 
Tsk and mean body 
temperature 
 
CWI & CON = BLa, 
PH, chloride, glucose, 
bicarbonate, 
potassium, sodium, 
PCO2, CK, IGF-1, 
testosterone, GH, 




adrenaline and plasma 
noradrenaline   
 
CWI > CON ↑ cooling 
rate 
 
CWI > CON ↓ PO2 40-
mins post-exercise 
 
CWI > CON ↑ 
perceived physical 
recovery and mental 
recovery 
CWI > CON ↓ 
perceived muscle 













cyclists (age = 
27 ± 7 years; 
VO2max = 63.9 ± 
7.2 mL·Kg-
1·min-1; PPO = 
418 ± 40 W) 
 
N = 18 
Pre: 
8 x 4-mins 
cycling @ 















CWI (14 ± 1°C, 
shoulder height) 
 
CWT (1-min CWI 
[14 ± 1°C], 3 x 2-
mins HWI [40 ± 
1°C] and ending 
with 1-min CWI) 
 
Passive rest (CON) 









CWI = 5-mins + 5-
mins passive seated 
 
CWT = 10-mins  
 
CON = 10-mins 
 
An additional 160-
mins passive seated 
for all conditions 















mental recovery, leg 
soreness, physical 
recovery 
No sig dif between conditions for HR and 
HRmax (during performance trial), time to 
completion, power output and perceived 
mental recovery 
 
CWI  ↓ HR during first 10% of performance 
trial vs CON & CWT (likely lower)  
 
CWI ↓ power output during first 10% of 
performance trial vs CON (likely lower) 
 
CWT ↑ power output between 40 – 80 % the 
duration of the performance trial vs CON 
(very likely higher)  
 
CWI & CWT ↑ ∆rMSSD vs CON (large 
effect size) 
 
CWI ↑ ∆rMSSD vs CWT (small effect size) 
 
CWI ↓ perceived general fatigue vs CON 
(very likely lower)  
 
CWT ↓ perceived general fatigue vs CON 
(likely lower)  
 
CWI & CWT ↓ perceived leg soreness vs 
CON (almost certainly lower)  
 
CWI ↑ perceived physical recovery vs CON 
(possibly higher)  
 
CWT ↑ perceived physical recovery vs CON 
(likely higher) 
 
CWI, CWT & CON = 
HR, HRmax, time to 
completion, power 
output and perceived 
mental recovery 
 
CON > CWI 
maintaining HR and 
power output during 




CWT > CON ↑ power 
output between 40-
80% duration of 
performance trial 
 
CWI & CWT > CON ↑ 
∆rMSSD and ↓ 
perceived leg soreness 
 
CWI > CWT ↑ 




CWI > CON ↓ 
perceived general 
fatigue and ↑ perceived 
physical recovery 
 

















cyclists (age = 
27 ± 6 years; 
VO2max = 64.8 ± 
6.0 mL·Kg-
1·min-1; PPO = 
415 ± 39 W)  
 
N = 11 
Pre: 













working up to 
15s per sprint 
and 2 x 2-min 
TT’s and 1 x 
5-min TT) 
CWI (shoulder 
height, 10 ± 1°C) 
 
Passive (CON) 










5-mins to return to 




























CWI attenuated ↓ sprint power day’s 1-3 vs 
CON (within-trial change mean ± 90%CL, 
CWI: +2.4 ±2.3 %, CON: -9.6 ±5.0 %) 
 
CWI attenuated ↓ sprint cadence day’s 1-3 vs 
CON (CWI: -2.1 ±1.5 %, CON: -4.1 ±1.8 %) 
 
TT mean power unclear between conditions 
 
CWI ↓ TT cadence days 1-3 vs CON (CWI: -
0.4 ±1.3 %, CON: +0.4 ±2.1 %)  
 
CWI ↑ mean HR during exercise days 1-3 vs 
CON (CWI: -2.3 ±1.3 %, CON: -3.9 ±1.4 %)  
 
HRmax , HRpost-session no sig dif between 
conditions 
 
CWI ↓ HRpost-recovery  day 1 vs CON (certainly 
lower) 
 
CWI ↑ rMSSDpost-recovery day 1 vs CON 
(certainly higher) 
 
RPE, tiredness & mental recovery unclear 
between conditions 
 








CWI > CON 
attenuating ↓ sprint 
power and cadence 
 




CWI > CON ↑ mean 
HR during exercise  
 
CWI & CON = HRmax, 
HRpost-session, RPE, 




CWI > CON ↓ HRpost-
recovery day 1 
 
CWI > CON ↑ 
rMSSDpost-recovery day 1 
 
CWI > CON ↓ leg 















(age = 32 ± 5 
years; VO2max = 
70.7 ± 7.9 
mL·Kg-1·min-1) 
 
N = 10 
Pre (Ex1): 
30-min 
cycling in heat 
(34 ± 0.2°C, 
39.4 ± 1.5 % 
rh,  15-min @ 







cycling in heat 
(34 ± 0.2°C, 
39.4 ± 1.5 % 
rh, 15-min @ 




Shoulder height for 
















AR (15-mins @ 




Intermittent CWI = 
5 x 1-min in bath, 
2-mins out of bath 
(29.2 ± 1.4°C, 58 ± 
2.1 % rh)   
 




recovery (34 ± 
0.2°C, 39.4 ± 1.5 % 
rh) 















All CWI conditions maintained total work vs 
AR (p < 0.05).  
 
ICWI 15°C ↑ total work Ex1 vs Ex2 but no  
sig dif (Ex1: 498 ± 47 kJ, Ex2: 500 ± 46 kJ,  
p > 0.05) 
 
No sig dif between CWI conditions for total 
work (p > 0.05) 
 
All CWI conditions ↓ post-recovery body 
temperature vs AR (CWI10: 34.6 ± 0.6 ° C, 
CWI15: 35.3 ± 0.6 °C, CWI20: 36.5 ± 0.5 °C, 
CCWI20: 36.1 ± 0.2 °C, AR: 38.2 ± 0.4 °C, 
p < 0.05) 
 
AR ↓ BLa post-recovery vs all CWI 
conditions (p < 0.05)  
 
ICWI10, ICWI15 & CCWI20 ↓ RPE mid-way 
through both exercise tasks vs AR (p < 0.05) 
 
CWI no sig dif post-exercise RPE vs AR  
(p > 0.05) 
 
AR ↑ HRpost-intervention vs all CWI conditions 
(ICWI10: 86 ± 12 b·min-1, ICWI15: 80 ± 7 
b·min-1, CWI20: 81 ± 12 b·min-1, CCWI20: 
81 ± 9 b·min-1, AR: 128 ± 7 b·min-1,  
p < 0.001) 
 
AR ↑ HRpost-recovery vs ICWI10, ICWI15 & 
CCWI20 (ICWI10: 74 ± 13 b·min-1, ICWI15: 
69 ± 8 b·min-1, CCWI20: 71 ± 8 b·min-1, AR: 
87 ± 11 b·min-1,)  
but not ICWI20 (ICWI20: 80 ± 6 b·min-1) 
All CWI conditions > 
AR maintaining total 




AR > all CWI 
conditions ↓ BLa  
 
ICWI10, ICWI15, 
CCWI20 > AR ↓ RPE 
during exercise 
 
All CWI conditions & 
AR = RPE post-
exercise 
 




AR > ICWI10, 













et al, 200834 
Endurance 
trained male 
cyclists (age = 
32.2 ± 4.3 years; 








66 max sprints 
(5-15s with a 
specific work 
to rest ratio of 
1:6, 1:3 or 1:1 
– rest is AR @ 
40-50% PPO) 
+ 9-min TT (2 











CWT (7 x 15°C 1-





























Sprints: CWT & CWI maintained/↑ mean 
power output days 4-5 (p < 0.01) and ↑ mean 
power over 5 days (CWI: +0.1 to +1.4 %, 
CWT: +0.5 to +2.2 %) vs CON 
 
CON & HWI ↓ mean power over 5 days 
(CON: -1.7 to -4.9 %, HWI: -0.6 to -3.7 %) 
 
TT’s: CWI & CWT ↑ total work vs HWI & 
CON days 4 & 5 (p < 0.05). Day 5 total work 
CWI = 160 ± 20 kJ, CWT = 161 ± 20 kJ,  
HWI = 156 ± 22 kJ & CON = 155 ± 22 kJ 
 
CON ↓ mean power by 2.6 – 3.8 % over 5 
days 
 
CWI & CWT ↑ mean power over 5 days 
(CWI: +0.1 to +1.0 %, CWT: 0.0 to +1.7 %,  
p < 0.05) 
 
HWI mean power ranged from an ↑ of 1.5%  
to a ↓ of 3.4% over the 5 days 
 
No sig dif Tre post-recovery  (CWI: 37.3 ± 0.2, 
HWI: 37.6 ± 0.2, CWT:  37.5 ± 0.2, CON: 
37.4 ± 0.2) and RPE  between conditions 
 
While no sig dif (p > 0.05) HWI ↓ post-
exercise HR vs CON on days 2 – 5 (ES: >0.6, 
medium effect)  
 
While no sig dif (p > 0.05) CWT & CWI ↑ 
post-exercise HR vs CON on days 4 – 5 
(CWT: ES: 0.6, CWI: ES:1.2)  
 
CWT & CWI > CON 
maintaining/↑ sprint 
mean power output 
days 4-5 
 
CWT & CWI > HWI 
& CON ↑ TT total 
work performed  
 
CWT & CWI > HWI 
& CON ↑ TT mean 
power output over 5 
days 
 
CWT, CWI, HWI & 
CON = Tre post-
recovery 
 
HWI > CWT, CWI & 
CON ↓ HR post-
exercise days 2-5 
 
CWT, CWI, HWI & 









et al, 201132 
Endurance 
trained male 
cyclists (age = 
33.7 ± 4.7 years; 




N = 10 
Pre & post: 
35-mins 
cycling in heat 
[32.8 ± 1.1 °C, 
43.6 ± 1.8 % 
rh] (15-mins 





AR @ 40% PPO 







Passive rest in a 
supine position for 
40-mins (32.8 ± 
1.1°C, 43.6 ± 1.8 % 
rh) 
 
15-min TT total work 




Limb blood flow 
(arm blood flow, leg 
blood flow & leg to 






AR↓ total work performed (pre to post ∆: -1.8 
± -1.1 %) 
 
CWI ↑ total work performed 
(pre to post ∆: +0.10 ± 0.7 %) 
 
CWI ↓ Tre post-recovery and post-exercise  
(p < 0.05) 
 
CWI ↓ leg and arm blood flow vs AR during 
recovery and post-recovery 
 
CWI ↓ arm blood flow post-exercise vs AR  
(p < 0.05) 
 
CWI ↑ leg to arm blood flow ratio vs AR 
during recovery 
 
No sig dif post-exercise blood flow ratio 
between conditions 
 
CWI ↓ HR during and post recovery vs AR 
(CWI: 78 ± 15 b·min-1, AR: 90 ± 11 b·min-1,  
p < 0.05) 
 
CWI ↓ HR during first 5-mins of exercise vs 
AR  
 
AR ↓ BLa post-recovery vs CWI (CWI: 4.5 ± 






CWI > AR ↑ total 
work performed  
 
CWI > AR ↓ Tre , leg 
and arm blood flow 
during recovery 
 
CWI > AR ↑ leg to 
arm blood flow ratio 
during recovery 
 
CWI & AR = leg to 
blood flow ratio post-
exercise 
 
CWI > AR ↓ HR  
 










(age = 29 ± 6 
years; VO2max = 
56.5 ± 5.0 
mL·Kg-1·min-1)  
 
N = 10 
Pre & Post: 
1-km maximal 
cycling TT in 
heat (35°C, 
40% rh) 
CWI (14°C, mid 
sternal level) 





(CON) [35 ± 0.3 

















CWI ↑ perceived recovery vs CON (CWI: 6.5 
± 2.1, CON: 4.5 ± 2.0, p < 0.01)  
 
Mean power no sig dif between conditions  
(p = 0.90) 
 
No sig dif time to completion between 
conditions  
 
No sig dif Tre between conditions post-
recovery 
 
CWI ↑ LnHFpost-recovery and post-exercise vs CON 
(post-recovery; p = 0.05, ES = 1.0, large, 
post-exercise; p = 0.11, ES = 1.2, large) 
 
CWI ↑ rMSSDpost-exercise vs CON (CWI: 9.9 ± 
4.9 ms, CON: 6.6 ± 1.3 ms, ES > 0.80, large)  
CWI > CON ↑ 
perceived recovery 
 
CWI & CON = mean 
power, time to 
completion, Tre  
 













cyclists (age = 
29 ± 6 years, 
VO2max = 67 ± 5 
mL·Kg-1·min-1; 
mean power = 
360-460 W) 
 
N = 12 
 Pre & Post: 
~4-min 
cycling TT 
(fixed load [40 





























4-min TT mean power no sig dif between 
conditions (CWI: 406 ± 43 W,  
CON: 405 ± 38 W, p = 0.66) 
 
CWI ↑ 30s mean power during 4-min TT vs 
CON (CWI: 435 ± 64 W, CON: 425 ± 63 W, 
p < 0.05) and also from 31-60s (p < 0.01) 
 
BLa no sig dif between conditions (p = 0.11) 
 
Perceived readiness no change between 
conditions (CWI & CON: 7 ± 1) 
CWI & CON = 4-min 
TT mean power, BLa 
& readiness 
 
CWI possible placebo 
lead to ↑ pacing profile 
as observed by an ↑ 









VO2max maximal oxygen uptake, N number of cyclists, VO2 oxygen uptake, rh relative humidity, Tsk skin temperature, Tmus muscle temperature, Tre rectal temperature, MVIC  
maximum voluntary isometric contraction, SMVIC maximum voluntary isometric contraction with superimposed electrical stimulation, TT time trial, W Watts/power output, PPO  
peak power output, RPE ratings of perceived exertion, CWI cold water immersion, CWT contrast water therapy, HWI hot water immersion, CCT cold compression therapy, RPM 
revolutions per minute, HR heart rate, BLa blood lactate concentration, CON control condition/passive recovery, HRmax maximum heart rate, pH potential of hydrogen, PCO2 
partial pressure of carbon dioxide, PO2 partial pressure of oxygen, CK creatine kinase, IGF-1 insulin-like growth factor 1, GH growth hormone, CRP C-reactive protein, IL-6 
interleukin 6, AR active recovery, rMSSD natural logarithm of the square root of mean squared differences of successive R-R intervals, HRV heart rate variability, LnHF natural 
logarithm of high frequency power density. 
Chan et al, 
201639 
Junior elite male 
cyclists (age = 
16 ± 1 year; 








75% PPO & 
15-min TT in 
heat (TT1, 





75% PPO & 
15-min TT in 
heat (TT2, 





CCT (15 °C, ankle 










seated in heat 















No sig dif TT2 mean power between 
conditions (p = 0.551) 
 
CWI ↓ core body temperature 15-mins  
during recovery vs CCT (p = 0.011) 
 
CWI ↓ core body temperature vs AR post-
recovery (p = 0.033) 
 
AR ↓ BLa vs CCT & CWI  
(AR: -75%, CCT: -62%, CWI: -62%) 
 
No sig dif RPE between conditions 
 
No sig dif HRrecovery between conditions 




CCT, CWI & AR = 
mean power, RPE & 
HRrecovery 
 
CWI > CCT ↓ core 
body temperature post 
treatment 
 









cyclists (age = 
29.7 ± 6.3 
years) 
 
N = 10 
Pre(s1): 



















CWI ↓ PPO vs CON (CON: -52.2 W [-4.7 %], 
CWI: -157.6 W [-13.7 %], p < 0.001) 
 
CWI ↓ mean power vs CON (CON: - 18.4 W 
[-2.3 %], CWI: -76.9 W [-9.5 %], p < 0.001) 
 
CWI ↓ mean HRpost-recovery vs CON (CON: 
+2.4 b·min-1 [+1.5 %], CWI: -6.8 b·min-1  
[-4.2 %], p < 0.02) 
CON > CWI 
attenuating ↓ PPO and 
mean power 
 






Contrast, Thermoneutral and Hot Water Immersion/Therapy 
Contrast water therapy (CWT) can be described as brief exposure to contrasted 
temperature, typically ranging from 15°C and below for the lower range and 35°C 
and above for the upper temperature range (table 5).6 It is proposed that CWT 
improves muscle soreness, inflammation and performance recovery.34  
Thermoneutral water immersion (TWI) can be described as exposure to temperate-
water, typically around 26°C and has been suggested effective in the removal of 
heat when exercise hyperthermia is of concern. Therefore, in order to maintain 
exercise performance in hot and humid conditions, TWI may be as effective as 
CWI.43 Indeed, it has been suggested that a reduction in muscle temperature can 
impair cross-bridge cycling, motor unit activation and enzyme activity rate;40 
therefore warranting further investigation for the use of TWI.  
Hot water immersion/therapy (HWI) involves immersing the body into water 
temperatures typically exceeding 36°C.34 Whether or not HWI is beneficial to 
exercise recovery and performance, or the physiological mechanisms by which 
HWI would impact these variables are unknown.34 
CWT has been shown more beneficial than passive rest alone and appears dose-
dependent with 6-mins [1-min hot water (38.4 ± 0.6°C): 1-min cold (14.6 ± 0.3°C)] 
shown to improve 15-min TT total work performed, where 12-mins and 18-mins 
had no significant difference on 15-min TT total work performed.4 There also 
appears to be an interaction with dose and intensity, with both 6 and 12-mins shown 
to improve 5 x 15s sprint cycling performance in the same study. However, 18-mins 
appears too long and ineffective at improving both sprint and TT total work 
performed.4 Furthermore, when used for 12-mins, CWT was most effective when 




(CWT6: 748 ± 19 W, CWT12: 772 ± 14 W, CWT18: 753 ± 13 W, CON: 754 ± 21 
W)4 and when the ratio of hot immersion increased to 1:2-mins (cold:hot); 12-mins 
of CWI improved 5-min TT mean power by 4.1 %.6 In support, 14-mins of CWT 
(7 x 15°C 1-min; 38°C 1-min, shoulder height) improved 9-min TT mean power by 
up to 1.7% over 5-days and sprint cycling mean power by up to 2.2% over the same 
5-day protocol.34 Additionally, the improvement in TT mean power from CWT was 
more beneficial than HWI, with mean power in the HWI condition ranging from an 
increase of 1.5% to a reduction of 3.4% over the 5 days. When examining total 
work performed, CWT again, was more beneficial than HWT (CWT = 161 ± 20 kJ, 
HWI = 156 ± 22 kJ & CON = 155 ± 22 kJ).34  
One study exhibited no improvements in time to completion or power output from 
the use of CWT when compared with a control.38 However, the performance trial 
in this study was based on a standardized amount of work (75% PPO x 15-mins) 
and interestingly, authors reported an increase in power output during 40-80% of 
the performance trial from the use of CWT. Furthermore and as described above, 
the same study that reported no benefit from the use of CWT used an extensive 
recovery duration (190-mins) which would have diluted the impact of the recovery 
intervention.  
CWT used between 6-14mins with a temperature of 38°C for hot water immersion 
and 15°C for the cold water immersion component and a ratio of 1:1-mins or 1:2-
mins for cold:hot has been shown to improve both TT total work performed, TT 
and sprint mean power output and sprint PPO. Performance benefits can be 
observed from as short as a 15s sprint, up to a 15-min TT.  
HWI appears detrimental to performance and as alluded to previously, a rise of core 




exercise performance and premature exercise termination.30, 31 Therefore, a 
recovery strategy that aims to expose athletes to HWI alone seems counterintuitive.  
These performance benefits were associated with a reduction in BLa of 2.7 mmol·L-
1
,
6 a decrease in perceived muscle soreness and whole body fatigue4, 6 and a 
reduction in core-temperature post-recovery when CWT was used for 12 & 18-
mins.4 A placebo effect may be responsible in part for the resultant performance 
benefits as the least effective duration (18-mins) was associated with an increase in 
perceived effort, while one of the most effective durations (12-mins) was reported 
as the perceived preferred duration in the one study that examined a dose-response 
relationship.4 However and in contrast, subjects reported a reduction in perceived 
motivation when CWT was used for 12-mins.4 
TWI has been shown greater than passive rest alone at reducing 20-km TT time to 
completion (TWI: 44 ± 2.7 mins, CON: 46.7 ± 5.4 mins, p < 00.05) and improving 
average speed (TWI: 27.4 ± 2.1 km/h, CON: 25.9 ± 2.4 km/h, p < 0.05).43 This 
improvement in performance was associated with a reduction in Tre and increased 
HR recovery (TWI: 62 ± 10 b·min-1, CON: 90 ± 8 b·min-1, p < 0.001). The use of 
TWI seems promising and future research should use four conditions and compare 
TWI, CWI, CWT and a CON condition to determine the most effective form of 




























state (age = 
19 ± 5 years; 




N = 9 
Pre: 
60-mins 
cycling in heat 
@ 70% 
VO2max (31.2 ± 
0.3 °C, 72 ± 









rh not described, 























TWI ↓ time to completion vs CON (TWI: 44 ± 2.7 
mins, CON: 46.7 ± 5.4 mins, p < 00.05) 
 
TWI ↑ average speed vs CON (TWI: 27.4 ± 2.1 
km/h, CON: 25.9 ± 2.4 km/h, p < 0.05) 
 
TWI ↓ post-exercise HR (TWI: 166 ± 10 b·min-1, 
CON: 168 ± 5 b·min-1) and post-recovery HR 
(TWI: 62 ± 10 b·min-1, CON: 90 ± 8 b·min-1,  
p < 0.001) vs CON 
 
TWI ↓ Tre 15-mins during recovery (p < 0.05) and 
post-recovery (post recovery ∆ 0.9 °C, p < 0.01) 
 
TWI ↓ Tre vs CON during entire 20-km TT  
(p < 0.05) 
 
TWI ↓ Tre post-exercise vs CON (TWI: 37.8 ± 0.4 
°C, CON: 38.5 ± 0.7 °C, p < 0.01) 
 
No sig dif Serum F2-isoprostanes and GSH:GSSG 











TWI > CON ↓ time to 
completion 
 
TWI > CON ↑ average speed 
 
TWI > CON ↓ HR 
 








et al, 20136 
Competitive 
male cyclists 
(PPO = 5.0 ± 
0.2 W/Kg) 
 













[~21 °C, ~30% 
rh] (CON)  
 
CWT (4 x 3-min 
to top thigh; 1-
min cold bath 
[10-12°C], 2-

































CWT ↑ mean power vs CON  
(368 ± 12 W, +4.1 ± 0.7 %; p < 0.001) and  
vs CS (+2.2 ± 0.8 %; p < 0.05) 
 
CS ↑ mean power vs CON  
(361 ± 15 W, +1.8 ± 1.0 %; p < 0.05) 
 
CWT & CS ↓ BLa vs CON (CWT: 5.7 ± 1.0 
mmol·L-1; p < 0.001, CS: 7.3 ± 1.2 mmol·L-1; p < 
0.05, CON: 8.4 ± 1.0 mmol·L-1) 
 
CWT ↓ BLa vs CS (p < 0.05)  
 
CWT & CS ↓ perceived muscle soreness vs CON 
(CWT: 1.1 ± 0.5 au; p < 0.001, CS: 1.6 ± 0.4 au; p 
< 0.001, CON: 3.2 ± 0.5 au) 
 
HR during exercise & RPE no sig dif between 




















CWT & CS > CON ↑ mean 
power & ↓ perceived muscle 
soreness and BLa 
 
CWT > CS ↑ mean power & 
↓ BLa 
 
CWT, CS & CON  = HR 













(age = 32.1 
± 7.6 years; 
VO2max = 




N = 11 
Pre (bout 1): 
 
6 x [5 x 15s 
sprint cycling 
& 3 x 5-min 
TT] 
 
Post (bout 2): 
 
6 x [5 x 15s 
sprint cycling 


















[2-hrs, 24.2 ± 
1.2°C. 48.1 ± 






1-min hot water 
(38.4 ± 0.6°C) 
 
 5s changeover 
 
1-min cold (14.6 
± 0.3°C)  
 
All trails seated 
at rest for the 
remainder of the 
duration of 





























CWT6 ↑ TT total work performed vs CON (CWT6: 
281 ± 17 kJ, CON: 277 ± 18 kJ) 
 
No sig dif CWT12 & 18 TT total work performed 
vs CON 
 
CWT6 & CWT12 ↑ sprints total work performed vs 
CON (CWT6: 263 ± 18 kJ, CWT12: 266 ± 15 kJ, 
CON: 255 ± 20 kJ) 
 
No sig dif CWT18 sprints total work performed vs 
CON 
 
CWT12 ↑ sprints PPO (CWT6: 748 ± 19 W, 
CWT12: 772 ± 14 W, CWT18: 753 ± 13 W, CON: 
754 ± 21 W) and perceived preferred duration vs all 
other conditions 
 
CWT12 & CWT18 ↓ core temperature post-
recovery vs CON (ES; CWT12 = 0.69, CWT18 = 
0.77) 
 
CWT12 ↑ core temperature post-exercise bout 2 vs 
CWT6 (ES = 0.61) 
 
No sig dif HRmean TT, HRmax sprints or RPE 
 
CWT18 ↑ 5-min TT bout 2 perceived effort vs 
CON (ES:1.2 ±1.0, very large) 
 
CWT12 ↓ perceived motivation vs CON (ES: -0.28 
±0.17, small) 
 
CWT6 & CWT18 ↓ perceived whole body fatigue 
post-recovery vs CON (CWT6: small effect, 
CWT18: large effect) 
 
CWT12 & CWT18 ↓ perceived muscle soreness vs 
CON (p < 0.05) 
CWT6 > CON ↑ TT total 
work performed 
 
CWT12, CWT18 & CON = 
TT total work performed 
 
CWT6 & CWT12 > CON ↑ 
sprints total work performed 
 
CWT18 & CON = sprints 
total work performed 
 
CWT12 > all other 
conditions ↑ sprints PPO and 
perceived preferred condition 
 
CWT12 & CWT18 > CON ↓ 
core temperature and 
perceived muscle soreness 
 
CWT12 > CWT6 ↑ core 
temperature post-exercise 
 
All CWT conditions & CON 
= HRmean TT, HRmax sprints 
and RPE  
 
CWT18 > CON ↑ 5-min TT 
perceived effort 
 
CWT12 > CON ↓ perceived 
motivation 
 
CWT6 & CWT18 > CON ↓ 
















(age = 32.2 
± 4.3 years; 
VO2max = 








66 max sprints 
(5-15s with a 
specific work 
to rest ratio of 
1:6, 1:3 or 1:1 
– rest is AR @ 
40-50% PPO) 
+ 9-min TT  










































Sprints: CWT & CWI maintained/↑ mean power 
output vs CON days 4-5 (p < 0.01) 
 
CON & HWI ↓ mean power over 5 days  
(CON: -1.7 to -4.9 %, HWI: -0.6 to -3.7 %) 
 
CWT & CWI ↑ mean power over 5 days  
(CWI: +0.1 to +1.4 %, CWT: +0.5 to +2.2 %) 
 
TT’s: CWI & CWT ↑ total work vs HWI & CON 
days 4 & 5 (p < 0.05). Day 5 total work  
CWI = 160 ± 20 kJ, CWT = 161 ± 20 kJ, HWI = 
156 ± 22 kJ & CON = 155 ± 22 kJ 
 
CON ↓ mean power by 2.6 – 3.8 % over 5 days 
 
CWI & CWT ↑ mean power over 5 days (CWI: 
+0.1 to +1.0 %, CWT: 0.0 to +1.7 %, p < 0.05) 
 
HWI mean power ranged from an ↑ of 1.5% to  
a ↓ of 3.4% over the 5 days 
 
No sig dif Tre post-recovery  (CWI: 37.3 ± 0.2, 
HWI: 37.6 ± 0.2, CWT:  37.5 ± 0.2, CON: 37.4 ± 
0.2) and RPE between conditions 
 
While not statistically significant (p > 0.05) HWI ↓ 
post-exercise HR vs CON on days 2 – 5 (ES: >0.6, 
medium effect)  
 
While not statistically significant (p > 0.05) CWT ↑ 
post-exercise HR vs CON on days 4 – 5 (ES: 0.6, 
medium effect)  
 
While not statistically significant (p > 0.05) CWI ↑ 
post-exercise HR vs CON on day 4 (ES: 1.2, large 
effect)  
 
CWT & CWI > CON 
maintaining/↑ sprint mean 
power output days 4-5 
 
CWT & CWI > HWI & CON 
↑ TT total work performed  
 
CWT & CWI > HWI & CON 
↑ TT mean power output over 
5 days 
 
CWT, CWI, HWI & CON = 
Tre post-recovery 
 
HWI > CWT, CWI & CON ↓ 
HR post-exercise days 2-5 
 

















= 27 ± 7 
years; 
VO2max = 
63.9 ± 7.2 
mL·Kg-
1·min-1; PPO 
= 418 ± 40 
W) 
 
N = 18 
Pre: 
8 x 4-mins 
cycling @ 











work = 75% 
PPO x  
15-mins)  
 




CWI [14 ± 
1°C], 3 x 2-mins 
HWI [40 ± 1°C] 


















CWT = 10-mins  
 





























No sig dif between conditions for HR and HRmax 
(during performance trial), time to completion, 
power output and perceived mental recovery 
 
CWI  ↓ HR during first 10% of performance trial vs 
CON & CWT (likely lower)  
 
CWI ↓ power output during first 10% of 
performance trial vs CON (likely lower) 
 
CWT ↑ power output between 40 – 80 % the 
duration of the performance trial vs CON  
(very likely higher)  
 
CWI & CWT ↑ ∆rMSSD vs CON 
(large effect size) 
 
CWI ↑ ∆rMSSD vs CWT (small effect size) 
 
CWI ↓ perceived general fatigue vs CON  
(very likely lower)  
 
CWT ↓ perceived general fatigue vs CON  
(likely lower)  
 
CWI & CWT ↓ perceived leg soreness vs CON 
(almost certainly lower)  
 
CWI ↑ perceived physical recovery vs CON 
(possibly higher)  
 




CWI, CWT & CON = HR, 
HRmax, time to completion, 
power output and perceived 
mental recovery 
 
CON > CWI maintaining HR 
and power output during first 
10% of performance trial 
duration 
 
CWT > CON ↑ power output 
between 40-80% duration of 
performance trial 
 
CWI & CWT > CON ↑ 
∆rMSSD and ↓ perceived leg 
soreness 
 
CWI > CWT ↑ ∆rMSSD ↓ 
and perceived general fatigue 
 
CWI > CON ↓ perceived 
general fatigue and ↑ 
perceived physical recovery 
 
CWT > CWI ↑ perceived 
physical recovery 
 
VO2max maximal oxygen uptake, N number of cyclists, rh relative humidity, TT time trial, TWI thermoneutral water immersion/therapy, CWT contrast water therapy, CWI cold 
water immersion, HWI hot water immersion/therapy, CON control condition/passive rest, HR heart rate, Tre rectal temperature, GSH reduced glutathione, GSSG oxidised 
glutathione, PPO peak power output, W/Kg watts per kilogram of bodyweight, CS compression stockings, BLa blood lactate concentration, RPE ratings of perceived exertion, 





Only one study to our knowledge, has examined electromyostimulation/electronic 
muscle stimulation (EMS) on cyclists during a cycling exercise protocol (table 6).8 
EMS involves attaching electrodes to the skin and emitting electrical current to the 
muscle belly or muscle nerve in order to create small muscle contractions; it is 
believed that this stimulus increases blood flow, promotes the removal of 
metabolites, decreases muscle soreness and ultimately restores neuromuscular 
function and exercise performance.44 In the study by Argus and colleagues,8 
participants were required to perform three bouts of 30s maximal sprint cycling, 
using a preload of 60s cycling at 4.5 W/Kg and 20-mins recovery between each 
bout. Whilst EMS was unable to significantly alter power results, a trend in BLa 
reduction was observed when compared with a passive control (4.9 ± 6.9 %, 
possibly beneficial) and EMS was also able to improve participants perceived 
recovery (0.7 ± 0.9, likely beneficial). As mentioned earlier, while a placebo effect 
may be responsible for the results observed, a belief questionnaire was used to 
attempt to control for a placebo effect. Only 2/8 participants accurately predicted 
the most effective recovery strategy therefore indicating that a placebo effect may 
not have been present. While further research is necessary to support the current 
findings, EMS appears to be an effective strategy for improving BLa clearance and 
perceptions of recovery. It should be noted that the EMS group performed the first 
sprinting bout at 15-20W greater than the opposing conditions and therefore while 
results were unclear, the potential for a performance improvement may occur in 































N = 11 
Pre:  






Post 1 (S2)  
& Post 2 (S3): 
30s max sprint 
cycling with 
60s preload  
@ 4.5W/Kg 
 
COMP (calf: 27 ± 6 
mmHg; thigh: 18 ± 2 
mmHg) 
 






Duration: 2 x 20-
mins between bouts 









COMP attenuated ↓ mean power vs CON S1 – S2  
(0.8 ± 1.2 %, possibly beneficial) & S1 – S3  
(1.2 ± 1.9 %; possibly beneficial) 
 
HUM attenuated ↓ mean power vs CON from S1 – S3  
(2.2 ± 2.5 %, likely beneficial)  
 
COMP no sig dif BLa or TQR vs CON (p > 0.05) 
 
HUM & EMS ↓ R2 BLa vs CON (HUM: 4.3 ± 7.9 %, 
possibly beneficial, EMS: 4.9 ± 6.9 %, possibly beneficial) 
EMS  ↑ R2 TQR vs CON (0.7 ± 0.9, likely beneficial) 
2 / 8 participants accurately predicted which strategy would 
enhance their recovery (belief). 
 
COMP & HUM > 
CON attenuating ↓ 
mean power 
 
COMP & CON = 
BLa & TQR 
 
HUM & EMS > 
CON ↓ BLa 
 
EMS > CON ↑ TQR 
 
Possibly no placebo 
effect (2/8 belief) 
 
 
N number of cyclists, W/Kg watts per kilogram of bodyweight, COMP compression garments/full length tights, EMS electromyostimulation/electronic muscle stimulation, 





Humidification Therapy (HUM) 
Only one study to our knowledge, has examined humidification therapy (HUM) on 
cyclists during a cycling exercise protocol (table 7).8 HUM encompasses the 
delivery of high flow rates (5-50 L·min-1) of warm (37°C) humidified air (100%) 
through a nasal cannula, causing a low level of positive airway pressure; while 
speculative, it is believed that this strategy can improve the efficiency of respiratory 
muscles, resulting in decreased oxygen consumption and requirement, reduced BLa 
concentration and improved perceptions of recovery.8, 45 In the study by Argus and 
colleagues,8 participants were required to perform three bouts of 30s maximal sprint 
cycling, using a preload of 60s cycling at 4.5 W/Kg and 20-mins recovery between 
each bout. It was identified that HUM attenuated the decrement in mean power over 
the three exercise bouts when compared with a passive control (2.2 ± 2.5 %, likely 
beneficial). In conjunction with an improvement in power measures, HUM was able 
to reduce BLa levels during the recovery period (4.3 ± 7.9 %, possibly beneficial).  
Again, while a placebo effect may be responsible for the results observed, a belief 
questionnaire was used to attempt to control for a placebo effect. Only 2/8 
participants accurately predicted the most effective recovery strategy therefore 
indicating that a placebo effect may not have been present. While further research 
is necessary to support the current findings, HUM appears a worthwhile tool for 
cyclists to increase anaerobic power measures and enhance recovery when there is 

































N = 11 
Pre:  






Post 1 (S2)  
& Post 2 (S3): 
30s max sprint 
cycling with 
60s preload  
@ 4.5W/Kg 
 
COMP (calf: 27 ± 6 
mmHg; thigh: 18 ± 2 
mmHg) 
 






Duration: 2 x 20-
mins between bouts 









COMP attenuated ↓ mean power vs CON S1 – S2  
(0.8 ± 1.2 %, possibly beneficial) & S1 – S3  
(1.2 ± 1.9 %; possibly beneficial) 
 
HUM attenuated ↓ mean power vs CON from S1 – S3  
(2.2 ± 2.5 %, likely beneficial)  
 
COMP no sig dif BLa or TQR vs CON (p > 0.05) 
 
HUM & EMS ↓ R2 BLa vs CON (HUM: 4.3 ± 7.9 %, 
possibly beneficial, EMS: 4.9 ± 6.9 %, possibly beneficial) 
EMS  ↑ R2 TQR vs CON (0.7 ± 0.9, likely beneficial) 
2 / 8 participants accurately predicted which strategy would 
enhance their recovery (belief). 
 
COMP & HUM > 
CON attenuating ↓ 
mean power 
 
COMP & CON = 
BLa & TQR 
 
HUM & EMS > 
CON ↓ BLa 
 
EMS > CON ↑ TQR 
 
Possibly no placebo 
effect (2/8 belief) 
 
 
N number of cyclists, W/Kg watts per kilogram of bodyweight, COMP compression garments/full length tights, EMS electromyostimulation/electronic muscle stimulation, 





Sports Massage (SM) 
Sports massage is commonly used to attenuate muscular fatigue46 and it is believed 
that through sports massage, there is an increase in blood flow which assists in the 
removal of metabolic waste.47 Additionally, sports massage with ozonized oil 
(SMOZO) (30% ozonized sunflower seed oil with 0.5% alpha-lipoic acid) has been 
shown to promote local microcirculation, cellular oxygen uptake and stimulate 
oxidative defensive enzymatic systems, which could further enhance recovery.48 In 
the study by Paoli and colleagues,48 SMOZO increased PPO following anaerobic 
cycling when compared with SM alone and a control condition (SMOZO: 370 ± 60 
W, SM: 340 ± 55 W, CON: 344 ± 56 W, p < 0.05). When comparing SM and a 
passive control, Bielik and colleagues46 revealed no statistically significant 
difference (CON: 876 ± 56 W, SM: 922 ± 51 W, p > 0.05) albeit, there was a 46W 
difference between conditions and had an effect size analysis been conducted, 
perhaps an effect would have been observed. Interestingly in a study by Monedero 
& Donne,49 SM resulted in a 7.7 ± 1.5 second increase in subsequent 5-km TT 
performance time, passive rest resulted in a greater 9.9 ± 1.6 second increase and a 
combination of both active recovery and SM was the most effective strategy, 
resulting in only a 2.9 ± 1.5 second increase in subsequent performance time (p < 
0.01). Due to the aforementioned potential mechanism for SM to increase the 
removal of metabolic waste, one would expect a consistent improvement in BLa 
from the use of SM. Nevertheless, results are confounding with CON shown to be 
more beneficial at reducing BLa 15-mins post exercise47 and AR shown to be more 
beneficial than SM at reducing BLa post-recovery (table 8).46, 47, 49 Consistent with 
performance results, both SMOZO and a combination of AR and SM, prove more 




Psychologically, SM both with and without ozonised oil was more beneficial than 
passive rest at reducing perceived fatigue48 nevertheless, SM with ozonised oil was 
still more effective than SM alone. SM was more beneficial than AR at reducing 
HR measures46, 49 but also revealed no difference when compared with a passive 
control or SMOZO.48 While more research is necessary to support the current 
findings, it appears that SM, SMOZO and a combination of AR and SM are more 


























= 19 ± 1 
years; 




N = 11 
Pre: 
3 x 30s WAnT 





30s WAnT (s4) 
 




AR (10-mins @ 20% 
VO2max and 10-mins  
















No sig dif PPO SM vs CON (CON: 876 ± 56 
W, SM: 922 ± 51 W, p > 0.05) 
 
AR ↑ PPO (CON: 876 ± 56 W, AR: 970 ± 69 
W, p < 0.05) and mean power output (CON: 
678 ± 45, AR: 746 ± 47 W, p < 0.05) vs CON 
 
No sig dif mean power SM vs CON (CON: 
678 ± 45 W, SM: 715 ± 33 W, p > 0.05) 
 
No sig dif fatigue index between conditions  
(% change in power output between the first  
5s and last 5s of the 30 second exercise period) 
(CON: 34 ± 8 %, SM: 33 ± 7 %, AR: 35 ± 8%) 
 
AR ↓ BLa vs CON and SM post-recovery 
(CON: 13.31 ± 2.9 mmol·L-1, AR: 7.49 ± 3.9 
mmol·L-1, SM: 14.68 ± 3.0 mmol·L-1,  
p < 0.01) 
 
AR ↑ HRrecovery vs CON and SM (CON: 105 ± 
9 b·min-1, AR: 125 ± 12 b·min-1, SM: 104  ± 8 








AR > CON ↑ PPO 
& mean power 
 
AR > CON & SM ↓ 
BLa post-recovery 
 














= 27 ± 3.5 
years; 
training 
years = 8 ±  
4 years) 
 
N = 15 
Pre: 














Passive rest (CON) 
 
Sports massage with 
Bioperoxoil (SMOZO) 
[30% ozonised sunflower 
seed oil with  0.5% 
alpha-lipoic acid]  
 
Sports massage (SM) 
 
Duration:  
5-mins passive seated on 
bike followed by 
 
16-mins per condition 
(~8-min prone and ~8-







Ramp test PPO 
 
Perceived fatigue  
 
 
SMOZO ↓ BLa vs SM & CON 13-mins post 
exercise when compared with immediately 
post-exercise (SMOZO: -34.3 %, SM: -22.5 
%, CON: -25.4 %) and at 20-mins when 
compared with 13-mins post exercise 
(SMOZO: -27.6 %, SM: -27.2 %,  
CON: -23.2 %) 
 
No sig dif HRrecovery between conditions  
(p > 0.05) 
 
SMOZO ↑ PPO vs SM & CON (SMOZO: 370 
± 60 W, SM: 340 ± 55 W, CON: 344 ± 56 W, 
p < 0.05) 
 
SMOZO & SM ↓ perceived fatigue vs CON  
(p < 0.033) 
 
SMOZO ↓ perceived fatigue vs SM  
(p < 0.033) 
 
 
SMOZO > SM & 
CON ↓ BLa 
 
SMOZO, SM & 
CON = HR 
 
SMOZO > SM & 
CON ↑ PPO 
SM with and 
without ozonised oil 
> CON ↓ perceived 
fatigue 
 






(age = 24.5 
± 3.98 years;  
VO2max = 




N = 10 
Pre: 




Sport massage (SM)  
 
AR (80rpm @ 40% 
VO2max) 
 










BLa AR significantly ↓ BLa post-recovery vs SM 
& CON 
(AR: -59.38 %, SM: -36.21 %, CON: -38.67 
%) 
 
CON ↓ BLa vs SM 15-mins post exercise (p < 
0.05) but not at 20 or 25-mins 
AR > SM & CON ↓ 
BLa 
 














(age = 25 ± 
1 years; 




= 364 ± 9 
W; training 
years = 5 ± 
0.3 years) 
 
N = 18 
Pre & post: 
5-km maximal 
effort cycling test 
Passive seated at rest 
(CON) 
 
AR (50% VO2max) 
 
SM (lower leg) 
 
Combined [AR & SM] 
(3.75min AR @ 50% 












Combined attenuated ↓ performance time vs 
CON, AR & SM (performance time increase 
between 1st and 2nd test; CON: 9.9 ± 1.6 
seconds, AR: 6.9 ± 1.3 seconds, SM: 7.7 ± 1.5 
seconds, combined: 2.9 ± 1.5 seconds,  
p < 0.01)  
 
Combined ↓ BLa vs CON & SM (p < 0.01) 
 
CON, SM & SM portion of combined ↓ 
HRrecovery vs AR & AR portion of combined 
during recovery (p < 0.05) 
Combined > CON, 
AR & SM 
attenuating ↓ 5km 
performance time 
 
Combined & AR > 
CON & SM ↓ BLa  
 
CON & SM > AR ↓ 
HRrecovery  
VO2max maximal oxygen uptake, N number of cyclists, WAnT wingate anaerobic cycling test, SM sports massage, AR active recovery, PPO peak power output, BLa blood lactate 




Static Stretching (SS) 
To our knowledge, the current research evaluating static stretching (SS) on cyclists 
using a cycling exercise protocol is limited to one study (table 9).50 SS, while 
beneficial for increasing range of motion (RoM), has been shown to temporarily 
decrease muscular power.51, 52 In the study by Kingsley and colleagues,50 SS 
resulted in no significant difference for any of the performance variables measured 
when compared with quiet rest (QR). Unfortunately, the details of how QR were 
performed was not described. While no significant difference was observed, SS 
resulted in a 0.86% increase in absolute PPO when compared with QR. SS increased 
relative peak power output (+0.86 %) and peak r·min-1 (+1.90 %) when compared 
with QR, but again, no significant difference was observed (p > 0.05). The use of 
Cohen’s d effect size analysis would have been a worthwhile tool to better evaluate 
the findings of the current study. As expected, SS improved RoM and resulted in a 
2.1cm increase in sit and reach distance (p < 0.05). With limited research, it is 
difficult to interpret the efficacy of SS. However, based on the current evidence it 
can be deduced that SS does not inhibit anaerobic cycling power if used for 3 x 30s 
per muscle and is a worthwhile inclusion where RoM is limited and an increase in 
RoM will prove advantageous to performance. Indeed, cycling has been linked to 
increased quadriceps muscle group, hamstrings muscle group and ITB tightness; 
which have been suggested to increase force on the knee and the potential for 
injury.53 Therefore performing quadriceps, hamstring and ITB stretching between 



























cyclists (age = 
21 ± 2 years; 




M = 9 
F = 4 
Pre:  
30-min cycling 




SS (3 x 30s per leg: 
Hamstrings, quadriceps, 
hip flexors and extensors 
& piriformis) 
 











SS ↑ Sit & reach from 25.2 ± 2.2 cm to 27.3 ± 1.7 
cm (p < 0.05) 
 
No sig dif between conditions for any 
performance variable (p > 0.05) 
 
SS ↑ absolute PPO  vs QR but no sig dif  
(+0.86 %, p > 0.05) 
 
SS ↑ relative PPO vs QR but no sig dif  
(+0.86 %, p > 0.05) 
 
SS ↑ RPMpeak vs QR but no sig dif  
(+1.90 %, p > 0.05) 
 
SS & QR = 
Absolute PPO, 









Active Recovery (AR) 
Active recovery can be described as gentle exercise between exercise bouts; 
believed to enhance metabolic waste removal and improve subsequent 
performance.39 With varying methods used in cycling literature (table 11), it is 
difficult to discern the optimal exercise intensity and duration for improving 
subsequent cycling performance (table 10). Connolly and colleagues54 discovered 
that AR used for 3-mins following 15s sprint cycling and repeated 6 times, resulted 
in an attenuation of the decrement in mean power when compared with a passive 
control (p < 0.002, F = 4.78). The use of AR in an anaerobic setting was further 
supported by Bielik and colleagues46 who identified that AR following 3 x 30s 
WAnT with 4-min recovery between intervals was able to significantly increase 
PPO (CON: 876 ± 56 W, AR: 970 ± 69 W, p < 0.05) and mean power output (CON: 
678 ± 45, AR: 746 ± 47 W, p < 0.05) in the following 30s cycling WAnT. The 
ability for AR to attenuate a decrement in subsequent performance is not limited to 
anaerobic power and has been shown beneficial when implemented between 5-km 
TT cycling bouts, with a performance time increase between pre and post 5-km TT 
tests of 6.9 ± 1.3 sec; where CON resulted in a greater increase of 9.9 ± 1.6 sec.49 
Unfortunately, further studies examining AR in cycling either did not use a passive 
control and compared AR against CWI, or they simply did not examine a 
subsequent performance bout.31, 32, 39, 47 Comparing against CWI makes it difficult 
to interpret performance findings, as CWI has been shown to improve subsequent 
performance when compared with passive rest.9, 30, 34 
AR was able to attenuate BLa concentration by around 21-54% more than that of 
passive rest. 46, 47, 49 However, one study revealed no significant difference in BLa 




= 0.37) and this could have been due to a shorter recovery duration of only 3-min 
intervals.54 The authors from this study hypothesised that perhaps measuring 
plasma lactate concentration as opposed to intracellular lactate concentration was 
not an effective method of assessing BLa given the short rest duration. It comes as 
no surprise that AR increases HR to a great degree than passive rest during recovery 
and this increase in HR, may be one of the contributing factors as to why AR is 
beneficial to post-exercise recovery.46, 49 It is theorised that an increase in HR, 
concomitant increase in blood flow and metabolic rate, are all factors which lead to 
improved recovery and performance.46 A novel form of AR has been examined by 
performing active recovery in water (ARW).55 Results indicated that ARW was 
more effective than passive recovery on land (PRL) and passive recovery in water 
(PRW) at reducing BLa concentration 15-60mins during recovery. Additionally, 
there was no change in HRV between conditions. However, when examining 
shorter resting protocols of up to 30-mins between exercise bouts, PRW and PRL 
appear more effective than ARW at improving HRV. Unfortunately no performance 
variables were examined.  
The current literature supports the use of AR as an effective strategy to increase 
both recovery and exercise performance in cyclists. Future research should ensure 
that a passive rest control condition is used and that subsequent performance is 
examined, to support the current body of evidence. ARW is a novel recovery 
strategy that warrants further research. Future studies should compare ARW with 

































Joanna Vaile et al., 
200831 
 
40% VO2max 15-mins No - 
 
Vaile et al., 201132 
 
40% PPO 15-mins No - 
 
Chan et al., 201639 
 
40% PPO 15-mins No = 
 
Monedero & Donne, 
200049 
 
50% VO2max 15-mins Yes + 








































cyclists (age = 
21.8 ± 3.3 
years) 
 
N = 7 
Pre & Post: 






AR (80rpm @ 1Kg 
resistance) x 3-mins 
 
Passive seated on bike 







AR attenuated ↓ in mean PPO vs CON  
(p < 0.002, F = 4.78) 
 
Mean power no sig dif between conditions (p = 0.57) 
 
BLa no sig dif between conditions (AR: 9.09 ± 2.37 
mmol·L-1, CON: 10.05 ± 2.84 mmol·L-1;  p = 0.37) 




AR & CON = 








(age = 19 ± 1 
years; VO2max 




N = 11 
Pre: 















AR (10-mins @ 20% 


















No sig dif PPO (CON: 876 ± 56 W, SM: 922 ± 51 W,  
p > 0.05) and mean power (CON: 678 ± 45 W,  
SM: 715 ± 33 W, p > 0.05) SM vs CON 
 
AR ↑ PPO (CON: 876 ± 56 W, AR: 970 ± 69 W,  
p < 0.05) and mean power output (CON: 678 ± 45, AR: 
746 ± 47 W, p < 0.05) vs CON 
 
No sig dif fatigue index between conditions (% change 
in power output between the first 5s and last 5s of the  
30 second exercise period) (CON: 34 ± 8 %,  
SM: 33 ± 7 %, AR: 35 ± 8 %) 
 
AR ↓ BLa vs CON and SM post-recovery (CON: 13.31 ± 
2.9 mmol·L-1, AR: 7.49 ± 3.9 mmol·L-1, SM: 14.68 ± 3.0 
mmol·L-1, p < 0.01) 
 
AR ↑ HRrecovery vs CON and SM (CON: 105 ± 9 b·min-1, 
AR: 125 ± 12 b·min-1, SM: 104  ± 8 b·min-1, p < 0.01)  
AR > CON ↑ 
PPO & mean 
power 
 
AR > CON & 
SM ↓ BLa 
post-recovery 
 
AR > CON and 











(age = 24.5 ± 
3.98 years;  
VO2max = 




N = 10 
Pre: 





Sport massage (SM)  
 
AR (80rpm @ 40% 
VO2max) 
 
Passive lying in a 





BLa AR significantly ↓ BLa post-recovery vs SM & CON 
(AR: -59.38 %, SM: -36.21 %, CON: -38.67 %) 
 
CON ↓ BLa vs SM 15-mins post exercise (p < 0.05) but 
not at 20 or 25-mins 
AR > SM & 
CON ↓ BLa 
 







cyclists (age = 
25 ± 1 years; 
VO2max = 68 ± 
1.7 mL·Kg-
1·min-1; PPO = 
364 ± 9 W; 
training years 
= 5 ± 0.3 
years) 
 
N = 18 




Passive seated at rest 
(CON) 
 
AR (50% VO2max) 
 
SM (lower leg) 
 
Combined [AR & SM] 
(3.75min AR @ 50% 
VO2max pre and post-



















Combined attenuated ↓ performance time vs CON, AR 
& SM (performance time increase between 1st and 2nd 
test; CON: 9.9 ± 1.6 seconds, AR: 6.9 ± 1.3 seconds, 
SM: 7.7 ± 1.5 seconds, combined: 2.9 ± 1.5 seconds,  
p < 0.01)  
 
Combined ↓ BLa vs CON & SM (p < 0.01) 
 
CON, SM & SM portion of combined ↓ HRrecovery vs AR 
& AR portion of combined during recovery (p < 0.05) 
Combined > 







AR > CON & 
SM ↓ BLa  
 
CON & SM > 











(age = 16 ± 1 
year; VO2max = 
64.7 ± 4.3 
mL·Kg-1·min-1 
 
N = 8 
Pre: 
15-mins cycling 
@ 75% PPO & 
15-min TT in 
heat (TT1, 




@ 75% PPO & 
15-min TT in 
heat (TT2, 






CCT (15 °C, ankle and 










10-mins passive seated 
in heat (31°C, 74% rh) 
 
15-mins per condition  
 
























No sig dif TT2 mean power between conditions  
(p = 0.551) 
 
CWI ↓ core body temperature 15-mins during recovery 
vs CCT (p = 0.011) 
 
CWI ↓ core body temperature vs AR post-recovery  
(p = 0.033) 
 
AR ↓ BLa vs CCT & CWI (AR: -75%, CCT: -62%, 
CWI: -62%) 
 
No sig dif RPE between conditions 
 
 






CCT, CWI & 
AR = mean 
power, RPE & 
HRrecovery 
 










AR > CWI & 













(age = 32 ± 5 
years; VO2max 




N = 10 
Pre (Ex1): 
30-min cycling 
in heat (34 ± 
0.2°C, 39.4 ± 
1.5 % rh,   
15-min @ 70% 







in heat (34 ± 
0.2°C,  
39.4 ± 1.5 % rh, 
15-min @ 70% 




Shoulder height for all 
CWI conditions 
 
Intermittent CWI, 10°C 
(ICWI10) 
 
Intermittent CWI, 15°C 
(ICWI15) 
 




20°C, in bath for entire 
15-mins (CCWI20) 
 
AR (15-mins @ 40% 
VO2max, 31.1 ± 2.6°C) 
 
Duration:  
Intermittent CWI = 5 x 
1-min in bath, 2-mins 
out of bath (29.2 ± 
1.4°C, 58 ± 2.1 % rh)   
 




recovery (34 ± 0.2°C, 



















AR ↓ Ex2 30-min cycling total work vs Ex1  
(-4.1 ± 1.8 %, p = 0.00).  
 
All CWI conditions maintained total work vs AR  
(p < 0.05).  
 
ICWI 15°C ↑ total work Ex1 vs Ex2 but no sig dif  
(Ex1: 498 ± 47 kJ, Ex2: 500 ± 46 kJ, p > 0.05) 
 
No sig dif between CWI conditions for total work 
(p > 0.05) 
 
All CWI conditions ↓ post-recovery body temperature vs 
AR (CWI10: 34.6 ± 0.6 ° C, CWI15: 35.3 ± 0.6 °C, 
CWI20: 36.5 ± 0.5 °C, CCWI20: 36.1 ± 0.2 °C,  
AR: 38.2 ± 0.4 °C, p < 0.05) 
 
AR ↓ BLa post-recovery vs all CWI conditions  
(p < 0.05)  
 
ICWI10, ICWI15 & CCWI20 ↓ RPE mid-way through 
both exercise tasks vs AR (p < 0.05) 
 
CWI no sig dif post-exercise RPE vs AR (p > 0.05) 
 
AR ↑ HRpost-intervention vs all CWI conditions (ICWI10: 86 
± 12 b·min-1, ICWI15: 80 ± 7 b·min-1, CWI20: 81 ± 12 
b·min-1, CCWI20: 81 ± 9 b·min-1, AR: 128 ± 7 b·min-1,  
p < 0.001) 
 
AR ↑ HRpost-recovery vs ICWI10, ICWI15 & CCWI20 
(ICWI10: 74 ± 13 b·min-1, ICWI15: 69 ± 8 b·min-1, 
CCWI20: 71 ± 8 b·min-1, AR: 87 ± 11 b·min-1,)  
















CCWI20 > AR 





AR = RPE 
post-exercise 
 




















cyclists (age = 
33.7 ± 4.7 
years; VO2max 
= 66.7 ± 6.1 
mL·Kg-1·min-1 
 
N = 10 
Pre & post: 
35-mins cycling 
in heat [32.8 ± 
1.1 °C, 43.6 ± 
1.8 % rh] (15-
mins @ 70% 
PPO; 15-min 
TT) 
CWI (15°C, shoulder 
height) 
 




15-mins per conditions 
followed by 
 
Passive rest in a supine 
position for 40-mins 
(32.8 ± 1.1°C, 43.6 ± 











leg blood flow 








AR↓ total work performed (pre to post ∆: -1.8 ± -1.1 %) 
 
CWI ↑ total work performed  
(pre to post ∆: +0.10 ± 0.7 %) 
 
CWI ↓ Tre post-recovery and post-exercise (p < 0.05) 
 
CWI ↓ leg and arm blood flow vs AR during recovery 
and post-recovery 
 
CWI ↓ arm blood flow post-exercise vs AR (p < 0.05) 
 
CWI ↑ leg to arm blood flow ratio vs AR during 
recovery 
 
No sig dif post-exercise blood flow ratio between 
conditions 
 
CWI ↓ HR during and post recovery vs AR  
(CWI: 78 ± 15 b·min-1, AR: 90 ± 11 b·min-1, p < 0.05) 
 
CWI ↓ HR during first 5-mins of exercise vs AR  
 
AR ↓ BLa post-recovery vs CWI  














CWI > AR ↓ 
Tre , leg and 




CWI > AR ↑ 





CWI & AR = 




CWI > AR ↓ 
HR  
 












= 26 ± 6 
years) 
 
N = 10 
Pre: 
30s WAnT with 
a load ~7.5% 
bodyweight and 
4 x 10s max 
sprints, 15s  rest 
between 
intervals 
PRW (in a swimming 
pool, horizontally with 
the help of floats) x 60-
mins 
 
ARW (85% LA on 
Water Bike, 28-32°C) 
30-mins + 30-mins 
PRW 
 








No sig dif between PRW & PRL for all variables 
measured 
 
BLa no sig dif between conditions 5-mins during 
recovery 
 
ARW ↓ BLa vs PRW & PRL 15-60mins during recovery 
(60-min BLa results: ARW: 3.19 ± 0.62 mmol·L-1,  
PRW: 4.71 ± 1.08 mmol·L-1,  
PRL: 4.52 ± 1.23 mmol·L-1, p < 0.05) 
 
ARW ↑ HRrecovery 5-30mins during recovery but not  
60-mins vs PRW & PRL (p < 0.05) 
 
ARW > PRW 




PRW & PRL > 
ARW ↓ 
HRrecovery up to 
30-mins during 
recovery but 
not 60-mins  
N number of cyclists, AR active recovery, CON control condition/passive rest, PPO peak power output, BLa blood lactate concentration, WAnT wingate anaerobic cycling test, 
SM sports massage, HR heart rate, VO2max maximal oxygen uptake, TT time trial, CWI cold water immersion, CCT cold compression therapy, RPE rating of perceived exertion, 









Based on the current body of evidence, the use of COMP has been shown beneficial 
at improving subsequent mean and maximal cycling power.6, 8, 26, 27 CWI used for 
5-mins at 14°C following 25-mins of submaximal cycling has been shown to 
improve 4-km TT time to completion in the heat and average power output.30 CWI 
used for 14-15mins at 15°C appears advantageous for improving 9-15min TT total 
work performed and repeated sprint power output.31, 32, 34 CWI also appears to be 
more beneficial than AR at improving total work performed.32 CWT used between 
6-14mins with 38°C HWI and 15°C CWI and a ratio of cold:hot of 1:1-mins or 1:2-
mins, has been shown to increase subsequent TT total work performed, TT & sprint 
mean power output and sprint PPO.6, 34 This performance benefit from CWT has 
been observed from durations as short as a 15s sprint and up to a 15-min TT.6, 34 
HWI alone appears to be detrimental to performance,34 while TWI has been shown 
to decrease 20-km TT time to completion and improve average cycling speed.43 The 
use of HUM has been shown to attenuate the decrement in sprint mean power and 
EMS may be beneficial.8 SMOZO could assist anaerobic cycling performance48 and 
SM may improve anaerobic cycling mean power and reduce 5-km TT time to 
completion.46, 49 A combination of recovery strategies should be explored further, 
as AR and SM combined, were more beneficial than AR or SM alone, at reducing 
5-km TT time to completion.49 The use of SS did not inhibit anaerobic cycling 
performance when performed for 3 x 30s per muscle and leg50 and may be a useful 
strategy for improving RoM and reducing the risk of knee injury when performed 
on the quadriceps muscle group, hamstrings muscle group and I.T.B between 
cycling exercise bouts.53 AR has been shown to attenuate 15s sprint PPO, 5km TT 





54 The impact of ARW on performance should be examined and compared with AR 
on land.  
Novel recovery strategies have been shown to positively impact recovery and 
subsequent exercise performance, and researchers should continue to build on the 
existing body of evidence while also seeking to explore new recovery strategies. 
Despite positive findings for the use of Intermittent Sequential Pneumatic 
Compression (ISPC)56, 57 using a cycling protocol, there have yet to be any studies 
examining ISPC for recovery in cyclists and this is a worthwhile intervention to 
examine in future research. Therefore, given the gap identified in the current 
literature, the aim of the study in chapter two of this thesis was to investigate the 







Chapter Two:  
Pneumatic Compression Fails to Improve 
Performance Recovery in Trained Cyclists 
*This chapter appears in the same format as it was accepted in the  






Purpose: To examine the efficacy of Intermittent Sequential Pneumatic 
Compression (ISPC) on exercise recovery and subsequent performance, when 
implemented between a 20-min cycling bout (simulated scratch race) and a 4-min 
cycling test (simulated individual pursuit), as experienced during an Omnium track 
cycling competition. Methods: Twenty-one (13 male, 8 female, mean ± SD; age: 
36 ± 14 years) trained cyclists completed a familiarisation trial followed by two 
experimental trials in a counterbalanced, crossover design. Participants performed 
a fixed-intensity 20-min cycling bout on a Wattbike cycle ergometer, followed by 
a 30-min recovery period where ISPC recovery boots or passive recovery (CON) 
was implemented. At the conclusion of the recovery period, participants performed 
a 4-min maximal cycling bout (4-minTT). Average power (Watts) for the 4-minTT, 
blood lactate concentration (BLa) and perceived total quality recovery (TQR) 
during the recovery period were used to examine the influence of ISPC. Results: 
There were no significant differences between trials for the 4-minTT (p = 0.08), 
with the effect deemed to be trivial (d = -0.08). There was an unclear effect (d 
±90%CI = 0.26 ±0.78, p = 0.57) for ISPC vs CON in the clearance of BLa during 
the recovery period. There was a small but not significant difference for TQR in 
favour of ISPC (d ±90%CI = 0.27 ±0.27, p = 0.07). Conclusion: There was little 
additional benefit associated with the use of ISPC to enhance recovery and 
subsequent performance when used during the recovery period between two events 
in a simulated Omnium track cycling competition. 
 







During congested competition schedules, like those often experienced at events 
such as the Olympic Games, recovery strategies are thought to alleviate post-
exercise fatigue and enhance subsequent performance.7, 8 The Omnium is a multi-
race event in track cycling at the Olympic Games, with short periods of recovery 
(as little as 30-mins) between 6 separate races.58 It is believed that events with brief 
periods of recovery such as the Omnium, create a substantial challenge for athletes 
and coaches to ensure optimal recovery is attained and has been one of the 
contributing factors for the development of acute recovery strategies aimed to 
enhance performance recovery.8, 9 It has been suggested that the power decrement 
following 20-mins of time-trial cycling (similar to a scratch race in the Omnium) is 
related to metabolic acidosis.59 Similarly, Bishop et al.,60 have revealed that a warm 
up yielding blood lactate levels as low as 5mmol·L-1, resulted in impaired 
subsequent exercise performance in trained athletes. Therefore, strategies designed 
to mitigate the potentially deleterious effects of metabolic acidosis in this setting 
may be important for improving recovery between exercise bouts where time to 
recover is limited. Furthermore, recent research has suggested that there is a 
positive correlation between an increase in blood flow and performance recovery 
between bouts of high-intensity cycling exercise61. Therefore, methods to enhance 
blood flow following exercise could be advantageous.  
 
Compression garments, or static compression, are thought to improve exercise 
recovery by enhancing venous return, and thereby assist in the removal of metabolic 
waste accumulated as a result of exercise.8 More recently, athletes have 





form of dynamic compression, to enhance recovery post-exercise.57 Similar to 
compression garments, ISPC derives from the medical sector where comparable 
devices have been used for the treatment of lymphedema and post-traumatic 
edema.62, 63 ISPC however, differentiates from compression garments; by exerting 
up to 4-times greater levels of pressure (~80mmHg) to the applied area, when 
compared with commercially available compression garments.64 Additionally, 
ISPC mimics the anatomical muscle-venous pump by providing a mechanical 
“squeezing” of the limb through inflatable cuffs/sleeves, from distal to proximal, in 
a sequential fashion.57 This dynamic application of pressure has been shown 
superior when compared to uniform/static compression (constant application of 
pressure) at enhancing venous blood flow and may further increase the removal of 
metabolic waste when compared to static compression methods.65.65 
 
Research evaluating ISPC for exercise recovery and/or subsequent performance is 
limited and contradictory, with an array of methods used to assess its efficacy.56, 57, 
62, 63, 66, 67 Hanson et al.57 and O’Donnell & Driller62 discovered a trend towards 
improved blood lactate clearance following cycling exercise with the use of ISPC 
(60-80mmHg) during recovery when compared to a passive control. Hanson 
examined twenty-one female club level lacrosse and field hockey athletes, to reveal 
a statistically significant improvement in blood lactate clearance 20-mins following 
a 1-min maximal cycling ergometer sprint (p = 0.04). However, Hanson and 
colleagues did not report any performance measures, making it difficult to evaluate 
the efficacy of ISPC. This was further supported by O’Donnell & Driller62 who 
reported a 94% positive likelihood and a small effect for improved blood lactate 





However, the improved blood lactate clearance did not translate into significant 
findings between ISPC and passive recovery on subsequent 5-km treadmill run time 
following the cycling exercise (p = 0.31; d = 0.07). Similarly, Northey et al.,66 
exhibited no significant difference from the use of ISPC (30-mins at ~80mmHg) to 
attenuate subsequent performance in twelve strength-trained males following a 
fatigue-inducing weight-lifting session. The authors discovered that ISPC was 
unable to attenuate a decrement in isokinetic quadriceps torque, squat jump height 
and counter movement jump height.  In addition to improved blood lactate 
clearance, Zelikovski et al,56 and Wiener et al,67 have both revealed improvements 
in subsequent performance with the implementation of ISPC when compared with 
a passive control. Zelikovski et al,56 studied eleven untrained but physically active 
male participants performing two cycling bouts at 80% of predicted VO2max until 
exhaustion and results revealed that a modified ISPC device (~50mmHg of pressure 
for 20-mins) increased time to exhaustion by 45% in the subsequent cycling bout. 
ISPC was also able to attenuate tibialis anterior fatigue in the study by Wiener et 
al67 who examined 8 male participants during 10-mins of treadmill walking at 
maximum walking speed and 2-mins of quasi-isometric suspension by strapping 
~10kg weights to both feet. The recovery protocol involved ISPC (3-mins at 
~80mmHg) applied to one leg, while the other leg acted as a passive control. 
Electromyography revealed that ISPC significantly improved the mean power 
frequency of the tibialis anterior (p <0.05).  
 
With contrasting results and limited literature, further research is necessary to 
determine the value of ISPC on exercise recovery and/or subsequent performance. 





these effects in trained cyclists, limiting the ecological validity of their results. 
Therefore, the current study aimed to examine the impact of ISPC on trained 
cyclists, when implemented between a maximal 20-min cycling bout (simulated 
scratch race) and a 4-min maximal test (simulated individual pursuit), as 
experienced during an Omnium track cycling competition. Indeed, the individual 
pursuit has been previously identified as being one of the key determinants of 
overall success in elite Omnium competition58, 68, and therefore, recovery from the 
previous event (scratch race) in the Omnium schedule, and the combination of these 




Twenty-one trained cyclists with an average of 7 years track racing experience and 
9 years road racing experience (male = 13, female = 8, mean ± SD; age: 40 ± 14 
and 29 ± 12 years , respectively; VO2max: 50 ± 10 ml∙kg
-1∙min-1 and 46 ± 5 ml∙kg-
1∙min-1, respectively), partaking in a minimum of 3 cycling sessions, for >30-mins 
per week volunteered to participate in the current study. The majority of participants 
(n=19) were regularly competing in track cycling races each week, where Omnium 
type events were simulated. All participants provided informed written consent 
before taking part and ethical approval for the study was obtained from the 










The current study involved participants attending a sport science laboratory for 3 
separate trials over a 3-week period. To mitigate a learning effect, participants 
initially performed a familiarisation trial of the testing protocol, which was to be 
used in the experimental trials. Following the familiarisation trial, in a randomised, 
counterbalanced, crossover design, participants performed two trials separated by 
>48 hours and <7 days. During the recovery protocol participants were assigned to 
either Intermittent Sequential Pneumatic Compression (ISPC) or passive 
recovery/control (CON). Participants were required to keep training the same for 
both testing weeks and instructed to avoid high intensity training <24-hrs prior to 
testing. All testing was performed on the same cycle ergometer (Wattbike Ltd, 
Nottingham, UK) and at the same time of day (± 1 hour), to minimise diurnal 
variation. Participants personal bicycle seat and handle-bar measurements were 
replicated on the Wattbike. The reliability of the Wattbike has been reported 
previously over a range of power outputs (50-300W), with a mean CV of 2.6% 
(95% CI 0.7-2.0%) in trained cyclists.69 To control for variability in nutrition, 
participants completed a 24-hr food diary and were instructed to replicate food and 
drink consumed for the subsequent trial. Participants were notified to refrain from 
caffeine (< 12 hours) and to arrive in a hydrated state. The exercise protocol used 
in the current study (fig 1.) was selected to closely mimic the 2016 Olympic Games 
schedule for the Omnium track-cycling event, simulating two of the six cycling 
races (scratch race and individual pursuit), with the scheduled recovery period 


























































Figure 1. Experimental Protocol. Warm up was self-selected and replicated for both ISPC 
and CON trials. W/up warm up, ISPC Intermittent Sequential Pneumatic Compression, CON 
control/passive recovery, Watts watts/average power, HR heart rate, RPE rating of perceived 
exertion, BLa blood lactate, TQR perceived total quality recovery, HRmax maximum heart rate.  
 
Procedures  
Familiarisation Trial  
The familarisation trial simulated the exact conditions of the experimental trials. 
However, during the 4-min maximal cycling effort (4-minTT), a metabolic cart 
(Parvo Medics, TrueOne® 2400, Sandy, UT, USA) was used to assess maximal 
oxygen uptake (VO2max) to characterise the training level of participants in the 
current study. The cart was calibrated using alpha gases according to manufacturers 
instructions. While measuring VO2max during a 4-min test may not be the commonly 
accepted method of VO2max assessment, shorter maximal cycling tests have been 
used previously and have been shown to produce similar results to incremental 
ramp VO2max tests.
37, 70 Therefore, given VO2max was used purely as an additional 
descriptor of participant characteristics, we opted for this method of testing. At the 
conclusion of the familiarisation trial and to provide insight for the likelihood of a 





the recovery intervention would enhance their recovery using a visual analog 
scale.29, 71 Participants were required to use a single vertical line to mark an 
unmarked horizontal line measuring 10-centimetres in length. Participants were 
only informed that 0cm, or the beginning of the line, meant they did not believe 
ISPC would enhance their recovery and the end of the line, or 10cm, indicated they 
were certain that ISPC would enhnace their recovery, as used previously.29 Care 
was taken throughout the experimental period so as to not influence participants’ 
perceptions to the efficacy of ISPC. 
 
Maximal 20-min Cycling Bout (20-minTT) 
Following a 5-min warm-up, participants performed 20-mins of maximal cycling 
on the Wattbike cycle ergometer, where average power, heart rate (Polar Electro 
Oy, Finland), blood lactate (Lactate Pro 2 Analyser, Shiga, Japan) and ratings of 
perceived exertion (Borg’s 6-20 scale)72 were recorded at the 20-min mark of the 
test. The only instruction given to participants’ was to perform the entire effort as 
maximally as possible. Average power output from the 20minTT of the first 
experimental trial was replicated for the following experimental trial, this was to 
ensure the same level of pre-load/fatigue before the 4-min TT. Additionally, during 
the replicated trial, average power output at 5-min intervals of the 20-minTT were 
replicated in an attempt to control the pacing profile between trials. The 20-min test 
was selected to simulate the duration necessary for elite athletes to complete the 
scratch race in the Omnium.58, 73 While the scratch race during competition often 
requires high-intensity surges, this can be somewhat variable from race-to-race, and 





Recovery Protocol (30-mins) 
Following cycling bout one (20-minTT), participants performed one of the two 
recovery conditions: 
a) Passive recovery/control (CON) – participants remained seated for 30-mins 
in the same  temperature-controlled laboratory used throughout the entire 
study (19.5 ± 1°C). 
b) Intermittent Sequential Pneumatic Compression (ISPC) – participants 
remained in a seated position with pneumatic compression sleeves 
(Recovery Boots, Recovery Pump, L.LC, USA) fitted to each leg. The ISPC 
device was set to a pressure of 80mmHg, with a deflation time of 30-
seconds, for a total duration of 30-mins, as used previously.62, 66 Sleeves 
were fitted according to the manufacturers instructions and individuals were 
sized appropriately to ensure the leggings covered from the toes to the 
inguinal crease of the upper leg. Each of the four chambers on each leg were 
filled with air in a sequential order (distal to proximal) and remained full 
until all chambers were filled; upon which the device deflated. This process 
was repeated for the entire duration of the recovery period.  
At 10, 20 and 30-mins, participants were required to rate their perceived recovery 
on the total quality recovery scale (TQR). The TQR scale ranged from 6 (very, very 
poor recovery) to 20 (very, very good recovery).8 Two minutes following the 
recovery period; when the participant was seated on the ergometer ready for cycling 
bout two, blood lactate was re-assesed. Blood lactate was assessed via a capillary 





The reliability of the Lactate Pro 2 has been deemed appropriate for research and 
has been reported elsewhere.74 
Kikuhime Pressure Measurement 
In a selection of participants (n = 18) interface pressure between the skin and ISPC 
was measured; to assess the actual pressure applied to the Quadriceps muscle group. 
The Kikuhime pressure monitor (MediGroup, Melbourne, Australia) sensor was 
placed on the Vastus Medialis Oblique. The Kikuhime pressure monitor has been 
shown to be a valid (ICC = 0.99, CV = 1.1%) and reliable (CV = 4.9%) tool for use 
in the sport setting.28  
 
Performance Test (4-minTT) 
Following the recovery period, participants performed a brief warm-up (Figure 1) 
and then a 4-min maximal cycling test on the Wattbike cycle ergometer. During the 
cycling test, participants were blinded to their power output and could only see time 
remaining. Average power output, maximum heart rate and rating of perceived 
exertion were acquired at completion and used for analysis. The 4-min cycling test 
was used to assess subsequent performance and simulated the approximate duration 
of the individual pursuit in the Omnium event.58 At the 2016 Olympic Games, the 
winning individual pursuit time during the Men’s Omnium was 4:14.9s, with the 
top 3 athletes in the individual pursuit, finishing with the medals for the overall 
Omnium. As mentioned previously, the individual pursuit has been identified as a 
key determinant to overall Omnium success58, 68. Acceptable  levels of reliability 
for the 4-min time trial on a Wattbike ergometer have been reported previously with 






Statistical analyses were performed using the Statistical Package for Social Science 
(V. 24.0, SPSS Inc., Chicago, IL). Descriptive statistics are shown as means ± 
standard deviation, unless stated otherwise. Normality of the data for all measures 
were verified visually with histograms and also by the Shapiro-Wilk test. A 
student’s paired t-test was used to compare 4-min TT power, HRmax and RPE 
measures for ISPC and CON, with an alpha level set at (p < 0.05) for all analysis. 
Standardised changes in the mean of each measure were used to assess magnitudes 
of effects and were calculated using Cohen’s d and interpreted using thresholds of 
0.2, 0.5, 0.8 for small, moderate and large, respectively.76 An effect size of 0.2 was 
considered the smallest worthwhile effect with an effect size of <0.2 considered 
trivial. The effect was deemed unclear if its 90% confidence interval overlapped 
the thresholds for small positive and negative effects.77 A two-way repeated 
measures ANOVA was used to determine differences between trials for change in 
blood lactate and TQR pre and post the recovery period. A Generalized Estimation 
Equation was used to analyse the TQR data pre and post recovery. Data was then 
divided into two groups for analysis, according to whether participants had positive 
perceptions to the efficacy of  ISPC  for recovery prior to the study (‘believers’, 
≥60% belief in the ability of ISPC to aid their recovery on a visual analogue scale) 









Mean pressure (± SD) applied by ISPC in a cohort of the study population (n=18), 
as identified using the Kikuhime pressure monitor, was 79.1 ± 6 mmHg.  
There were no significant differences in power output (Watts) (Both CON and 
ISPC: 221 ± 50 W), mean HR (Both CON and ISPC: 167 ± 19 beats·min-1) HRmax 
(CON: 174 ± 18 beats ·min-1; ISPC: 176 ± 15 beats ·min-1) or RPE (Both CON and 
ISPC: 16 ± 2)  for the 20-minTT between ISPC and CON trials (p > 0.05).  
There were no significant differences between ISPC and CON trials for average 
Watts and RPE for the 4-minTT (p > 0.05, Table 1). 4-minTT average Watts 
revealed a 5 ± 13 Watt mean difference in the ISPC trial. This difference was 
associated with a trivial effect size of 0.08 (Table 1).  
There was an unclear effect and no statistically significant two-way interaction 
between ISPC and CON for pre to post recovery BLa concentration (F(1,20) = .327, 
p = 0.57, Table 2).  There was a small effect size (d = 0.27) but no statistically 
significant two-way interaction between ISPC and CON for pre to post recovery 
TQR p = 0.07, Table 2).  
Maximum heart rate was significantly higher in ISPC when compared to CON at 
the end of the 4-minTT (178 ± 15 and 175 ± 14 bpm ± SD, respectively, p = 0.003, 
Table 1). This difference was associated with a trivial effect size (d = 0.17)  
When separated for perceived ‘belief’ in ISPC and its effect on recovery, there were 
no significant differences (p > 0.05) between the ‘believers’ (n=16) and ‘non-
believers’ (n=5) (Figure 2). This difference was associated with a trivial effect size 










Table 12. 4-min Maximal Cycling Performance (4-minTT) Results for Intermittent Sequential Pneumatic Compression (ISPC) and Control 
(CON) Trials and Effect Sizes for the Comparison of Differences Between Trials (±90% confidence intervals). # Represents significant 
difference (p < 0.05). 
 
 ISPC 
(mean ± SD) 
CON 
(mean ± SD) 
ISPC - CON 
Effect size (±90%Cl) 
4-minTT (Watts) 
 
289 ± 64 
 




4-min Max Heart Rate 
(bpm) 
 
178 ± 15 
 





4-min RPE (Borg’s 6-20 
scale) 
 
19 ± 2 
 















Table 13. Pre and Post Recovery Measures for Intermittent Sequential Pneumatic Compression (ISPC) and Control (CON) Trials and Effect 
Sizes for the Comparison of the Change Between Trials (±90% confidence intervals). # Represents significant difference (p < 0.05). 
 
 ISPC 
(mean ± SD) 
 
CON 
(mean ± SD) 
   
ΔISPC - ΔCON 
Effect size (±90%Cl) 




10.8 ± 3.8 
 
3.6 ± 2.4 
 
10.8 ± 3.2 
 








11 ± 2 
 
17 ± 2 
 
11 ± 2 
 









Figure 2. Mean Difference (±SD) Between ISPC (Intermittent Sequential 
Pneumatic Compression) and CON (passive recovery) for the 4minTT 
(Watts) for ‘Believers’ (n=16) and ‘Non-believers’ (n=5). d = 0.17, trivial. 
 
Discussion 
Results from the current study suggest that the use of ISPC does not enhance 
performance recovery when compared to passive recovery. While the use of ISPC 
improved 4-minTT cycling performance by ~5W when compared to passive 
recovery, this outcome was not statistically significant and resulted in a trivial effect 
size. Blood lactate and perceived TQR revealed no significant difference, although, 
a trend towards improved TQR ratings from the use of ISPC was observed with a 
small effect size when compared with CON for pre to post TQR. 
The performance results of the current study are in agreement with the findings 
from both O’Donnell & Driller62 and Northey et al,66 who revealed no difference 
for subsequent performance from the use of ISPC when compared with passive 
recovery and are in contrast to Zelikovski et al,56 & Wiener et al,.67 As previously 
































an untrained population in the latter studies. Trained populations yield faster 
recovery rates between exercise bouts when compared to their untrained 
counterparts.   
BLa concentration in the current study were also consistent with that of O’Donnell 
& Driller62 and Zelikovski et al,56 who revealed no significant differences between 
ISPC and CON. Albeit, O’Donnell & Driller62 revealed a trend towards improved 
BLa concentration with a small effect, where the current study revealed an unclear 
effect. This trend for BLa clearance from the use of ISPC was further supported by 
Hanson and colleagues57 who revealed a significant difference following 1-min 
maximal cycling. Unfortunately Hanson and colleagues57 did not examine a 
subsequent performance measure, making it difficult to determine the effect of BLa 
on performance. TQR revealed no significant difference between trials, however, 
there was a trend for ISPC enhancing TQR. This was evidenced by a small effect 
size (d = 0.27) in favour of ISPC when compared to CON. This result for perceived 
recovery is in agreement with O’Donnell and Driller62, who revealed a 68% 
likelihood that ISPC was beneficial compared to CON. 
Interestingly, results revealed a significant increase in HRmax  at the completion of 
the 4-minTT and this difference resulted in an increase of 3bpm. This is similar to 
that of Zelikovski et al,56 who saw an increase in HRmax of 8bpm with the use of a 
modified ISPC device.  
Contrary to the study by Brophy-Williams et al,29 this investigation did not reveal 
a significant difference when accounting for a psychological benefit from believing 
the intervention would enhance recovery (placebo effect). Studies examining 




is very difficult to account for in recovery research, the authors would suggest this 
is a worthwhile inclusion for future research.  
 
Practical Applications 
Findings from the current study suggest that ISPC does not improve simulated track 
cycling individual pursuit performance, if used during the recovery period 
following a simulated scratch race. A limitation of the current study was that we 
did not test this intervention on elite cyclists. High performance programmes are 
often reluctant to include an intervention that would deviate from their programme 
and elite athletes are somewhat difficult to obtain access to for research studies on 
novel strategies, therefore it has become commonplace to first test interventions on 
lesser trained individuals before replicating the studies in a higher-trained 
population.  The current study examined just 2 of the 6 events in an Omnium event 
and did not include intermittent bursts of high-intensity cycling as can be observed 
when riders attack during a scratch race. We acknowledge that the design could 
have more closely mimicked the exact demands of the scratch race and the 
individual pursuit, however, in order to ensure internal validity, we opted for a more 
controlled simulation. Future research should employ the testing of recovery 
strategies during an actual Omnium event in highly-trained atheltes.  
 
Conclusion 
The current study has shown that ISPC was unable to enhance recovery when 
used for 30-mins between two cycling bouts (20-min maximal time-trial and a 4-
min maximal test). While there was a small trend towards improved perceptions 




Our results are in agreement with other studies using similar ISPC recovery 
protocols. We would suggest there is little, if any, additional benefit in using ISPC 
to enhance performance recovery in this setting. 
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Recommendations for Future Recovery 







To better understand the effect of recovery modalities on cycling recovery and 
subsequent performance, future research might consider: 
 
 The use of a pressure monitoring device (e.g. Kikuhime) when examining 
compression garments, to determine whether there is a relationship between 
garment pressure exerted and resultant benefits in cycling performance. 
 The use of a visual analogue scale to examine ‘belief’ in the recovery 
intervention, with an attempt to better understand the placebo effect. 
 Controlling the intensity of the fatiguing exercise protocol to ensure a 
similar level of fatigue leading into the performance trial.  
 Comparing Thermoneutral Water Immersion, Cold Water Immersion, 
Contrast Water Therapy and a control condition, to determine the most 
effective form of water immersion for performance recovery. 
 Comparing active recovery in water with active recovery on land and a 
control condition, to determine if active recovery in water is more beneficial 
than the way in which active recovery is currently performed.  
 Continuing to explore the use of Humidification Therapy and 
Electromyostimulation in differing cycling events with highly-trained 
cyclists. 
 The exploration of a combination of multiple recovery strategies and 
whether the impact on recovery and subsequent performance is greater than 




 The examination of Intermittent Sequential Pneumatic Compression (ISPC) 
during an actual Omnium event in highly-trained athletes. 
 Evaluating the varying brands and modes of Intermittent Sequential 
Pneumatic Compression. 
 Examining the effects of Intermittent Sequential Pneumatic Compression 
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Appendix Two:  
Participant Information 
Dear Participant,  
  
You are being invited to take part in a research study, which will help determine the 
effect of Intermittent Sequential Pneumatic Compression (Recovery Boots) on 
exercise recovery and subsequent performance. Before you volunteer to take part in 
this study, it is important that you understand what it will involve. Please take the 
time to read the following information carefully and if there is anything that is not 




The aim of this study is to determine the impact of Recovery Boots on exercise 




Recovery from training and competition is a fundamental aspect of athlete regimen. 
Incorporating appropriate recovery is believed to enhance training and competition 
quality and quantity. Intermittent sequential pneumatic compression is a technique 
used in the medical setting to treat patients with venous insufficiencies. More 
recently, this technique has been adapted to the sport setting to enhance athletic 
recovery. However, its claims are largely anecdotal and research is necessary to 
determine its efficacy.   
  
Recovery Boots (RecoveryPump, TX, USA) are a commercially available product 
that utilises intermittent sequential pneumatic compression to assist in recovery from 
exercise. The boot encloses the leg, from the foot to the upper thigh. Four 
compartments inflate sequentially at pressures of ~80mmHg.   
  
To date, no study has examined the impact of Recovery Boots on recovery and 




Healthy male and/or female cyclists with no contraindications to vigorous exercise 
and who meet the following criteria will be selected.   
  




● Available to attend the University of Waikato Sport Science Lab in the 
Avantidrome, Cambridge, New Zealand on two separate occasions. Each visit 
will last approximately 80-mins. 
● Aged between 18 and 50 years.  
● Undertaking three or more training sessions for cycling per week (30-
mins or longer).  
● Have competed in a track race over the past 6 months.  
 
And NOT have the following:  
● Injury, illness or health issues which would disrupt performance e.g. 
lower limb injury ● Injury, illness or health issues which would endanger 
your health e.g. heart condition  
  
  
If you meet all of the aforementioned criteria then you can choose to participate in 
this research project.   
  
It is up to you to decide whether or not to take part.  If you do decide to take part you 
will be given this information sheet to keep and asked to sign a consent form.  If you 
decide to take part, you are still free to withdraw at any time without reason. You 





Participants will be required to attend the University of Waikato Sport Science Lab at 
the Avantidrome in Cambridge, NZ for three consecutive weeks. 
  
The first week will be a familiarisation trial where you get a feel for the study and the 
following two weeks will be experimental trials.   
  
The outline of the testing session is highlighted in the table below:  
   
Testing Protocol  
  
Warm-up One: 5-min cycling on Wattbike   
Bout One: 20-min cycling on Wattbike  
Recovery: 30-mins.   
Recovery Boots (experimental) / passive seated (control)  
Warm Up Two: 5-min cycling on Wattbike   
Bout 2: 4-min max effort on Wattbike   
 
Blood Lactate Testing: A finger-prick blood sample will be taken at the beginning 
and end of the recovery period to analyse blood lactate levels.   
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During your familiarisation trial, a metabolic cart will be used to analyse VO2max 




In a randomised crossover design, participants will perform one of two conditions 





Participants will be seated with Recovery Boots fitted to both legs and operated as 











What you will gain from participating in the study?  
  
As a participant, you will benefit from experience with the research process and gain 
knowledge about the area of research. You will be involved in innovative research, 
which will provide valuable information on recovery for cyclists. We will also 
identify for you the following which will assist your Cycling Coach and/or Strength 
and Conditioning Specialist:  
1) 20-min average power  
2) 4-min average power  
3) Blood lactate concentration post 20-min cycling effort and post 30-
min recovery protocol  
4) VO2max (indication of fitness level)  
  
 All information collected about you during the course of the research project will be 
kept strictly confidential.  You will be identified by a code number and all personal 





This research study has been approved by the University of Waikato Human Research 
Ethics Committee (health).  
Official study number: HREC_Health#2  
  
Please contact us should you have any cultural concerns with regards to 
collecting/storing/disposing of blood and/or if you would like a cultural advisor 
involved.  
  
Any inquiries regarding requirements and procedures used in this study are 
encouraged.  Please contact us if you have any questions. Contact details over the 
page. 
Contact Details for Researcher and Supervisor  
 
Ryan Overmayer  
Principal Researcher  
The University of Waikato  
Mobile: 027 8122 741  
E-mail: rovermayer@gmail.com  
  
Dr. Matt Driller  
Principal Supervisor  
The University of Waikato  






Appendix Three:  
Research Informed Consent Form 
 
Informed Consent form  
  
Project Title:  The Impact of Intermittent Sequential Pneumatic Compression on  
Exercise Recovery and Subsequent Performance  
  
Principal Researcher: Ryan Overmayer   
Principal Supervisor: Dr. Matt Driller  
  
This is to certify that I                                                   hereby agree to participate as a 
volunteer in a scientific investigation as an authorised part of the research program 
of the University of Waikato under the supervision of Ryan Overmayer.  
  
The investigation and my part in the investigation have been defined and fully 
explained to me by Ryan Overmayer and I understand the explanation. A copy of the 
procedures of this investigation and a description of any risks and discomforts have 
been provided to me and discussed in detail with me.  
  
● I have been given an opportunity to ask whatever questions I may have had 
and all questions have been answered to my satisfaction.  
  
● I understand that I am free to withdraw consent and to discontinue 
participation in the project or activity at any time, without disadvantage to 
myself.  
  
● I understand that I am free to withdraw my data up until the point of analysis 
(after the last lab test) without disadvantage to myself.  
  
● I understand that any data will remain anonymous with regard to my identity 
through a coding system. The data will be made publishable, so every effort 
will be made to ensure confidentiality, however this cannot be guaranteed.  
  
● I certify to the best of my knowledge and belief, I have no physical or mental 
illness or weakness that would increase my risk to participate in this 
investigation.  
  
● I am participating in this project of my own volition and I have not been 




● I have been asked and affirm that I have no concerns with Tikanga/Maori 
protocol/customs in regards to collecting/storing/disposing of blood.   
  
● I have been given the opportunity to involve a cultural advisor and affirm that 
I feel culturally safe.    
  
Signature of Subject: ________________________________________                
Date: ____/____/____  
  
I, the undersigned, was present when the study was explained to the subject/s in 
detail and to the best of my knowledge and belief it was understood.  
 
Signature of Researcher: ____________________________________              
Date:___/____/___  
  
Contact Details for Researcher and Supervisor  
  
Ryan Overmayer  
Principal Researcher  
The University of Waikato  
Mobile: 027 8122 741  
E-mail: rovermayer@gmail.com  
  
Dr. Matt Driller  
Principal Supervisor  
The University of Waikato  






Appendix Four:  
Pre-test Medical Questionnaire 
 
 
First Name/s   Surname 
Date of Birth  / /   
Gender (circle) Male  Female 
 
Please answer the following questions by circling the appropriate response, or filling in the 
blank. 
 
1. How would you describe your present level of activity? 
Sedentary Moderately Active Active Highly Active 
 
2. How would you describe your present level of fitness? 
Unfit Moderately Fit Trained Highly Trained 
 
3. How would you consider your present body weight? 
Underweight Ideal Slightly Over Very 
Overweight 
 
4. Smoking habits: Are you currently a smoker? Yes No 
 
How many do you smoke? ……per day 
 
Are you a previous smoker? Yes No 
 
How long is it since you stopped? ……..years 
 











5. Do you drink alcohol? Yes No 
If you answered Yes, do you have? 
 
An occasional drink                     A drink everyday                  More than one 
drink a day 
 
6. Have you had to consult your doctor in the previous six months?  Yes No 






7. Are you presently taking any form of medication?    Yes No 






8. As far as you are aware, do you suffer from or have you ever suffered 
from?(circle if yes to any) 
a. Diabetes b. Asthma 
c. Epilepsy d. Bronchitis 
d. Any form of heart complaint* e. Raynaud’s Disease 
f. Marfans Syndrome* h. Aneurysm/embolism* 
i. Anaemia j. Haemophilia* 
 
 
9. *Is there a history of heart disease in your family?                                     
Yes           No 
10. *Do you currently have any form of muscle or joint injury?                             
Yes          No 
11. Have you had to suspend your normal training in the previous two weeks?   
 Yes         No 
12. Please read and answer the following questions: 
a. Are you suffering from any known serious infections?                                          
Yes          No 
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b. Have you had jaundice within the previous year?                                                
Yes          No 
c. Have you ever had any form of hepatitis?                                                            
Yes          No 
d. Are you HIV antibody positive?                                                                              
Yes          No  
 
e. Have you ever been involved in intravenous drug use?                                         
Yes          No 
 
f. For females, are you currently, or in the previous 6 months, 
pregnant?       Yes                 No 
 
13. As far as you are aware, is there anything that might prevent you 






    Consent of Athlete/Participant 
 
 
         ___________________________                                   ____/_____/____ 
     
        Athlete/Participant Signature                                    Date 
 
 
         ____________________________                           _________________________    ____/_____/___ 
  
        Guardian name (if age less than 16 yrs)            Athlete/Participant Signature    Date 
 
 
        ___________________________                        _________________________    ____/_____/___ 
 
       Witness name                                                 Signature                                  Date 
If the answer to any of the above questions is yes then: 
 




Rating of Perceived Exertion Scale 
 
6 No Exertion at All 
7 Extremely Light 
8  




13 Somewhat Hard 
14  
15 Hard (Heavy) 
16  
17 Very Hard 
18  
19 Extremely Hard 
20 Maximal Exertion 
 
Borg, G.A., (1982). Physiological basis of physical exertion. 








Do you believe Recovery Boots will aid your recovery? 











Appendix Seven:  
The Effects of Tissue Flossing on Ankle Range of Motion 
and Jump Performance 
Abstract 
 
Objectives: Tissue compression and partial vascular occlusion using band flossing 
results in re-perfusion of blood to the muscle tissue that may ultimately increase range 
of motion (ROM) and reduce risk of injury. However, the effect of band flossing on 
ankle ROM and jump performance is yet to be evaluated. Design: In a crossover design, 
participants performed a number of tests pre and post the application of a floss band to 
one ankle (FLOSS), with the contralateral ankle acting as the control (CON).  
Setting: University laboratory. Participants: 52 recreational athletes (29 male/ 23 
female). Main outcome measures: Pre and post measures included a weight-bearing 
lunge test (WLBT), ankle dorsiflexion (DF) and plantarflexion (PF) ROM, and single 
leg vertical jump height and velocity. Results: FLOSS resulted in significant 
enhancements in all test measures pre to post (p<0.01), with no significant changes pre 
to post for CON (p>0.05). All pre to post changes were associated with small effect 
sizes for FLOSS compared to CON. Conclusion: Floss bands applied to the ankle 
increase dorsiflexion and plantarflexion ROM and improve single-leg jump 
performance in recreational athletes. The results from this study suggest that floss 
bands may be used for injury prevention and athletic performance. 
 





The anecdotal use of floss/mobility bands, or “tissue flossing”, amongst athletes is 
becoming a popular strategy to increase joint range of motion (ROM), enhance 
prevention or rehabilitation from injury and improve athletic performance, despite 
limited evidence for its efficacy. Tissue flossing involves the wrapping of a thick rubber 
band around a joint or muscle, partially occluding blood-flow while often 
concomitantly performing ROM tasks for 1-3 minutes. This technique gained 
popularity through the book by Starrett and Cordoza (2013), where the authors 
introduced floss band compression for increasing ROM and postulated that the 
potential mechanisms behind the benefit of using floss bands may be attributed to 
fascial shearing and/or reperfusion of blood to the muscle.  
While the research studies regarding tissue flossing are currently lacking, the 
mechanisms involved may be similar to that of ischemic preconditioning/blood-flow 
occlusion/restriction training, whereby reperfusion of blood to the occluded area, 
enhanced growth hormone and catecholamine responses are suggested to improve 
exercise performance (Reeves et al., 2006; Takarada et al., 2000). Furthermore, in 
animal models, ischemic preconditioning has been shown to improve muscle 
contraction efficiency, possibly by enhancing muscle force and contractility (Lawson 
& Downey, 1993) and/or via increased efficiency of excitation-contraction coupling 
(Pang et al., 1995). 
To the authors knowledge, the extent of research examining the effect of tissue flossing 
in an athletic setting is limited to two studies, published as conference proceedings 
(Bohlen et al., 2014; Plocker, Wahlquist, & Dittrich, 2015). Bohlen et al., (2014) 
examined the effects of 14 days of band flossing combined with joint mobilization and 
resistive exercise on calf blood flow and plantar/dorsiflexion strength in five 
participants. Participants performed unloaded squats, heel raises, active dorsiflexion 
and passive ankle mobilization with floss bands applied to one knee while the 
contralateral leg acted as the control. Dorsiflexion peak torque increased 22% in the 
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treatment leg (p=0.06), while there was no change in the control leg. The authors also 
reported no change in blood-flow parameters between legs following the 14-day study. 
In contrast, Plocker et al., (2015) studied the effect of applying floss bands to both 
shoulders in 17 male athletes in an acute setting. Subjects attended an experimental 
session whereby the researchers wrapped both shoulders with a floss band, and led 
subjects through shoulder ROM exercises. Upon band removal, ROM measurements 
(internal and external rotation) were taken using a goniometer. A 3D accelerometer 
was then used to measure upper extremity power during the bench press. The control 
session involved the same shoulder exercises without the use of the floss band 
modality. The study reported that despite trends towards improvements, there were no 
significant increases in ROM or upper-body power (p>0.05) following the floss band 
treatment when compared to the control. Researchers concluded that it was difficult to 
cover the entire shoulder (rotator cuff complex) with the wrapping technique, 
potentially limiting the effectiveness of improving shoulder ROM. Other joints, such 
as the ankle, may be easier to cover using the floss band wrapping technique. 
Ankle dorsiflexion ROM is an important component in the absorption of lower limb 
load when landing from a jump, as common in most sports (Malliaras, Cook, & Kent, 
2006). When landing from a jump, the forefoot usually contacts the ground and then 
the ankle moves into dorsiflexion. Indeed, it has been suggested that reduced ankle 
dorsiflexion range may be a risk factor for the development of patellar tendinopathy 
and is also a risk factor for anterior cruciate ligament (ACL) injury and other lower-
limb injuries in athletes (Fong, Blackburn, Norcross, McGrath, & Padua, 2011; Gabbe, 
Finch, Wajswelner, & Bennell, 2004; Malliaras et al., 2006). Moreover, restricted 
dorsiflexion has been implicated as a contributing factor in overuse injuries of the lower 
limb and foot (Warren & Jones, 1987). 
Given the relatively novel technique of tissue flossing has only been examined in two 
studies, with contrasting results, the modality requires further research. Furthermore, it 
is well known that improvements in ankle ROM may lead to enhanced performance in 
many sport, exercise and rehabilitation settings (Conradsson, Fridén, Nilsson-Wikmar, 
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& Ang, 2010; Larson, 2014; Malliaras et al., 2006; Tabrizi, McIntyre, Quesnel, & 
Howard, 2000), making it an obvious area for investigation. Therefore, the aim of the 
current study was to evaluate the use of floss bands applied to the ankle joint, on 
subsequent ankle ROM and jump height in recreational athletes. 
Methods 
Participants 
Fifty-two recreational athletes (29 male/ 23 female, mean ± SD; age: 20 ± 4 years) 
volunteered to participate in the current study. Participants were recruited through a 
University sport science under-graduate program. To be eligible for the study, all 
participants were required to be participating in regular physical exercise sessions (>3 
times per week) and free from lower-limb injuries (hip, knee or ankle) that may have 
affected their ability to perform the single-leg jumps. Written informed consent was 
obtained from each participant, and ethical approval was obtained from the Human 
Research Ethics Committee of the institution. 
 
Experimental Design 
Participants performed a number of lower-leg tests pre and post application of a floss 
band (FLOSS) or no floss band (CON) to the ankle-region. For each participant, the 
ankle that had no floss band served as the control for pre and post testing, while the 
ankle with the floss band served as the experimental treatment. Participants attended a 
sport science laboratory for a single testing session. Following the pre tests, in a 
randomised (computerised random number generator), counterbalanced design, 
researchers applied a floss band (Life Flossbands, Sydney, Australia), to either the right 
(n = 26) or left (n = 26) ankle of participants. Post tests were then performed in the 
same order as the pre tests. The order of tests for all participants were as follows: the 
weight bearing lunge test, plantarflexion ROM, dorsiflexion ROM and single leg 




Figure 1 – The floss band ankle bandaging technique used by researchers 
 
Methodology 
Weight-bearing lunge test (WBLT) 
The WBLT was performed pre and post flossing as a measure of dorsiflexion range of 
motion. Participants placed their foot along a measuring tape on the floor, with their 
big toe against the wall and both their toe and heel on the centerline of the measuring 
tape.  
Participants were then asked to progressively move their toe further back from the wall 
on the measuring tape, repeating the lunge movement until the maximum distance at 
which they could tolerably lunge their knee to the wall without heel lift was found. 
Measurement was made using the tape measure from the tip of their big toe to the 
wall. The weight-bearing lunge test (WBLT) is a functional and reliable method to 
indirectly assess dorsiflexion by measuring the maximal advancement of the tibia over 
the rearfoot in a weight-bearing position (Bennell et al., 1998). Previous investigators 
have reported robust inter-tester and intra-tester reliability associated with the 
assessment of WBLT performance in healthy adults, with high levels of test-retest 
reliability demonstrated (standard error of measurement = 1.1°, 95% CI = 2.2) (Bennell 




Dorsiflexion and Plantarflexion ROM 
 
Both dorsiflexion (DF) and plantarflexion (PF) range of motion tests were performed 
using a handheld manual goniometer (RBMS®, USA) pre and post flossing. Tests were 
performed while participants were in a supine position. The center of the goniometer 
was placed just below the lateral malleolus of the ankle, with one arm lined up through 
the lateral aspect of the fibula and the other arm lined up with the 5th 
metatarsophalangeal joint. Participants were instructed to perform a maximal 
dorsiflexion movement and a maximal plantarflexion movement and measurements 
(degrees) were taken for analysis. Acceptable intra-tester reliability for assessing ankle 
ROM using a manual goniometer has been reported previously (ICC = ~0.85) (Youdas, 
Bogard, & Suman, 1993). 
 
Single-leg vertical jump test (JUMP) 
Data regarding the maximal jump height (JUMPH) and the peak jump velocity 
(JUMPV) were measured using a linear position transducer (Gymaware, Kinetic 
Athlete, Canberra, Australia) pre and post flossing. The Gymaware device was 
calibrated before each jump, according to manufacturer’s instructions. JUMPH was 
measured in metres, while JUMPV was measured in m.s-1. Single-leg countermovement 
jumps were performed and the best of three attempts for each leg was recorded and 
used for subsequent analysis. High levels of validity (typical error of estimate of 0.00m 
for jump height and 0.01m/s for peak and mean velocity) for the Gymaware device 
have been reported elsewhere (Hori & Andrews, 2009). 
 
Kikuhime pressure measurement 
In a selection of participants (n = 12), interface pressure between the skin and the floss 
band was measured to assess the level of compression (mmHg) achieved by the 
wrapping technique. The Kikuhime pressure monitor (MediGroup, Melbourne, 
Australia) sensor was placed on the anterior aspect of the tibia on the midline between 
the lateral and medial malleolus (Figure 2). The Kikuhime pressure monitor has been 
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shown to be a valid (ICC = 0.99, CV = 1.1%) and reliable (CV = 4.9%) tool for use in 
the sport setting (Brophy-Williams, Driller, Halson, Fell, & Shing, 2014).  
 
 
Figure 2 – The Kikuhime pressure monitoring device applied under the floss band. 
Application of floss band 
A standard ankle-bandaging technique was used by researchers by applying the floss 
band accordingly: Across the transverse of the foot, aligned with the distal head of the 
metatarsals of the foot. The wrap circulated around the foot twice, followed by 3 wraps 
completed in a figure 8 (to lateral malleolus, around the achilles, to medial malleolus, 
towards the distal head of the 5th metatarsal, around the bottom of the foot and back to 
the beginning). Each subsequent wrap overlapped the previous by ~50%, before 
securing the remainder of the band underneath the final wrap (Figure 1). Once the floss 
band was applied, in a seated position, participants performed an active ROM task - 20 
repetitions of plantarflexion and dorsiflexion, simultaneously on both the CON and 
FLOSS ankles. Participants were instructed to perform both plantarflexion and 
dorsiflexion to their extreme ranges of motion and completed the mobility exercises 
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within two minutes. After two minutes, the floss band was then removed and the 
participants were instructed to stand up and walk around for one minute to allow for 
blood flow to return to the foot. 
Statistical Analysis 
Statistical analyses were performed using the Statistical Package for Social Science (V. 
22.0, SPSS Inc., Chicago, IL). A two-way repeated measures ANOVA was performed 
to determine the effect of different treatments (FLOSS or CON) over time (pre/post) 
on all measured variables, with a Bonferroni adjustment if significant main effects were 
present. Analysis of the studentized residuals was verified visually with histograms and 
also by the Shapiro-Wilk test of normality. A Student’s paired t-test was used to 
determine pre to post differences for each condition and also between treatments for 
pre test values. Descriptive statistics are shown as means ± standard deviations unless 
stated otherwise. Standardized changes in the mean of each measure were used to 
assess magnitudes of effects and were calculated using Cohen’s d and interpreted using 
thresholds of 0.2, 0.5, 0.8 for small, moderate and large, respectively (Cohen, 
1988). An effect size of ±0.2 was considered the smallest worthwhile effect with an 
effect size of <0.2 considered to be trivial. The effect was deemed unclear if its 90% 
confidence interval overlapped the thresholds for small positive and negative effects 




Mean pressure (± SD) applied by the floss band in a cohort of the study population 
(n=12), as identified using the Kikuhime pressure monitor, was 182 ± 38 mmHg. There 
were no significant differences between FLOSS and CON for any of the measured 
variables pre test (p>0.05). There was a statistically significant interaction between 
treatment (FLOSS/CON) and time (pre/post) for the WBLT, DF and JUMPv measures 
(p<0.01), but not for PF or JUMPH (p>0.05, Table 1). FLOSS resulted in significant 
115 
 
enhancements in all test measures pre to post application of the floss bands (WBLT, 
PF, DF JUMPH, JUMPv, p<0.01), while there were no significant differences pre to 
post CON (p>0.05). All measures were all associated with small effects sizes in favour 
of FLOSS when compared to CON (Table 1). 
The WBLT resulted in a 1.8 cm increase pre to post for FLOSS, compared to a 0.2 cm 
increase in CON. ROM for both PF (+5 degrees) and DF (-7 degrees) were improved 
in FLOSS, compared to just +2 degrees for PF and -1 degree for DF in CON. Similar 
increases were observed pre to post for JUMPH in both FLOSS and CON (0.04 m and 
0.02 m, respectively). JUMPV was further enhanced (pre to post) in FLOSS (0.15 m.s
-









Table 1 – Pre and post measures (mean ± SD) for floss band (FLOSS) and control (CON) trials and effect sizes for the 
comparison of change between groups (±90% confidence intervals). # Represents significant difference between pre and post 
(p<0.01), * Represents significant intervention * time interaction between groups (p<0.01).  
 FLOSS 
 (mean ± SD) 
CON 
(mean ± SD) 
FLOSS - CON 
Effect size 
(±90%CI) 
 Pre Post Pre Post  
WBLT (cm) 10.9 ± 6.0 12.7 ± 6.5# 11.4 ± 6.7 11.6 ± 6.5 
0.29 ±0.09* 
small 
PF (degrees) 162 ± 16 167 ± 14# 162 ± 13 164 ± 14 
0.22 ±0.19 
small 
DF (degrees) 95 ± 12 88 ± 13# 93 ± 12 92 ± 12 
-0.49 ±0.21* 
small 
JUMPH (m) 0.23 ± 0.07 0.27 ± 0.08# 0.24 ± 0.07 0.26 ± 0.15 
0.28 ±0.32 
small 







The current study is the first to investigate the use of floss bands applied to the ankle 
on dorsiflexion and plantarflexion ROM and subsequent vertical jump performance. 
The findings from our study show significant improvements in all ROM measures as 
well as single-leg jump performance following the application of a floss band while 
performing ~2 minutes of active ROM exercises, in a group of 52 recreational athletes 
(p<0.01, Table 1). All results were associated with a small effect size in favour of the 
floss band treatment. The small but significant effects found for tissue flossing may 
provide practical implications for numerous settings including the use of the technique 
to enhance injury prevention, injury rehabilitation and athletic performance. 
While this is the first study to evaluate the effect of floss bands on the ankle joint, our 
findings are in contrast to the only other previous study evaluating the effect of floss 
bands on ROM and performance in an acute setting (Plocker et al., 2015). Plocker et 
al. (2015) did not find any significant improvements in shoulder ROM or upper-body 
power following the application of floss bands. The only other study, to our knowledge, 
to evaluate the use of floss bands in an athletic setting, assessed the use of this technique 
in a chronic (14-day) setting while applying the band to the knee during daily exercises. 
Similar to the findings in the current study, the authors reported benefits to dorsiflexion 
measures following the experimental period. The potential improvements to ankle 
ROM following band flossing may apply to areas other than athletic performance, 
including their potential as an injury prevention method. 
Although the majority of studies investigating ACL injury and landing biomechanics 
have focused on the knee and hip joints, considerably less attention has been devoted 
to the ankle. Ankle plantarflexors and dorsiflexors play a substantial role in the 
absorption of landing forces (Malliaras et al., 2006). Indeed, Fong et al. (2011) has 
shown that greater passive ankle dorsiflexion ROM was associated with greater knee-
flexion displacement and smaller ground reaction forces during landing in 35 active 
participants. These biomechanical results are considered to lower the risk factors for 




indicated that any techniques that increase plantarflexor extensibility and dorsiflexion 
ROM may attenuate ACL injury risk by placing the lower extremity in a position  
consistent with reduced ACL loading. Given we were able to significantly improve 
both plantarflexion and dorsiflexion ROM through the use of floss bands in the current 
study, possibly through the fascial shearing mechanism (Starrett & Cordoza, 2013), 
this may prove to be an appropriate technique to use in addition to a warm-up before 
sporting events where jumping is required, in order to decrease the risk of lower-limb 
injury. Furthermore, results from the current study would suggest that jump 
performance can be enhanced following the application of floss bands to the ankle joint. 
The physiological mechanisms by which performance may be improved following 
band flossing are difficult to determine, and since these were not measured in the 
current study, any theories are somewhat speculative. However, the partial vascular 
occlusion effect that band flossing has on the joints may cause a number of 
physiological responses following the removal of the band. These responses may 
include reperfusion of blood to the area and altered hormonal responses (Takano et al., 
2005). More specifically, research has shown that following occlusion (~200mmHg) 
to the upper leg using a tourniquet during resistance exercise, growth hormone and 
norepinephrine levels significantly increase ~15 minutes after the occlusion is released 
(Reeves et al., 2006; Takarada et al., 2000). Furthermore, Morales et al, (2014) has 
suggested that elevated acute norepinephrine are associated with improved vertical 
jump ability. It is therefore plausible that these same hormonal responses were achieved 
in the current study with floss bands applied (~182mmHg), potentially contributing to 
enhanced jump performance ~5 minutes following the removal of the floss bands. 
Lawson & Downey (1993) suggested that ischemic preconditioning in rat skeletal 
muscles led to improved force and contractility as well as decreased fatigue. However, 
the mechanisms behind repeated muscle-contractions are likely to be different to those 
of one-off jump performance and mechanistic human research is still lacking. 
We would recommend that these physiological mechanisms, including the localised 
blood-flow and hormonal responses following band flossing, are measured in future 




timeline of both performance and ROM improvements with band flossing. For 
example, the current study showed improvements in jump performance and ROM ~5 
minutes following the application of a floss band. Whether or not these benefits are still 
observed 5+ minutes following the use of this technique are yet to be determined. A 
limitation of the current study was that only one ankle was assessed with the floss band. 
It would be appropriate to apply the floss bands to both ankles and evaluate jumping 
and other lower-body performance parameters (e.g sprinting, leg strength and power). 
A further limitation in the current study was the lack of a placebo/sham condition. 
Indeed, the psychological advantage that may be associated with the intervention 
cannot be discounted. Future research may consider a parallel-group design that 
incorporates a placebo group. 
 
Conclusion 
The current study is the first study to describe the use of band flossing to improve ankle 
ROM and jump performance in recreational athletes. The potential benefits regarding 
the results of this study may have a significant impact in the sport setting. More 
specifically, our results would suggest that including band flossing on the ankle joint 
before taking part in any sports that require jumping actions, may not only improve 
performance, but may also provide a novel strategy for injury prevention, through 
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